Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
J Infect Dis
    September 2021
  1. ZEEVAT F, Luttjeboer J, Paulissen JHJ, van der Schans J, et al
    Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom.
    J Infect Dis. 2021 Sep 15. pii: 6370470. doi: 10.1093.
    >> Share

  2. VAN PRAET JT, Vandecasteele S, De Roo A, Vynck M, et al
    Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid-19 vaccination in Covid-19 naive nursing home residents.
    J Infect Dis. 2021 Sep 13. pii: 6369254. doi: 10.1093.
    >> Share

  3. MATTHIAS KA, Connolly KL, Begum AA, Jerse AE, et al
    Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.
    J Infect Dis. 2021 Sep 8. pii: 6366578. doi: 10.1093.
    >> Share

  4. KIM SS, Chung JR, Belongia EA, McLean HQ, et al
    mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged >/=16 Years in the United States, February - May 2021.
    J Infect Dis. 2021 Sep 8. pii: 6366365. doi: 10.1093.
    >> Share

  5. MCMILLAN M, Koehler AP, Lawrence A, Sullivan TR, et al
    'B Part of It' School Leaver study: a repeat cross-sectional study to assess the impact of increasing coverage with meningococcal B (4CMenB) vaccine on carriage of Neisseria meningitidis.
    J Infect Dis. 2021 Sep 6. pii: 6364883. doi: 10.1093.
    >> Share

  6. RICHMOND PC, Hatchuel L, Pacciarini F, Hu B, et al
    Persistence of the immune responses and cross-neutralizing activity with Variants of Concern following two doses of adjuvanted SCB-2019 COVID-19 vaccine.
    J Infect Dis. 2021 Sep 4. pii: 6364149. doi: 10.1093.
    >> Share

  7. PECK ME, Hampton LM, Antoni S, Ogbuanu I, et al
    Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018.
    J Infect Dis. 2021;224.
    >> Share

  8. AHMED SS, Lessa FC, Coradin H, Sanchez J, et al
    High Prevalence of Vaccine-Type Infections Among Children with Pneumococcal Pneumonia and Effusion After 13-Valent Pneumococcal Conjugate Vaccine Introduction in the Dominican Republic.
    J Infect Dis. 2021;224.
    >> Share

  9. FRANCOIS WATKINS LK, Milucky JL, McGee L, Sine St-Surin F, et al
    Nasopharyngeal Carriage of Streptococcus pneumoniae Among Young Children in Haiti Before Pneumococcal Conjugate Vaccine Introduction.
    J Infect Dis. 2021;224.
    >> Share

  10. KWAMBANA-ADAMS BA, Cohen AL, Hampton L, Nhantumbo AA, et al
    Toward Establishing Integrated, Comprehensive, and Sustainable Meningitis Surveillance in Africa to Better Inform Vaccination Strategies.
    J Infect Dis. 2021;224.
    >> Share

  11. RABOBA JL, Rahajamanana VL, Andriatahirintsoa EPR, Razafindrakoto AC, et al
    Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar.
    J Infect Dis. 2021;224.
    >> Share

  12. NAKAMURA T, Cohen AL, Schwartz S, Mwenda JM, et al
    The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019.
    J Infect Dis. 2021;224.
    >> Share

  13. SHRESTHA S, Stockdale LK, Gautam MC, Gurung M, et al
    Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal.
    J Infect Dis. 2021;224.
    >> Share

  14. YAMBA K, Mpabalwani E, Nakazwe R, Mulendele E, et al
    The Burden of Invasive Bacterial Disease and the Impact of 10-Valent Pneumococcal Conjugate Vaccine in Children <5 years hospitalized for Meningitis in Lusaka, Zambia, 2010-2019.
    J Infect Dis. 2021;224.
    >> Share

  15. KABORE L, Adebanjo T, Njanpop-Lafourcade BM, Ouangraoua S, et al
    Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys.
    J Infect Dis. 2021;224.
    >> Share

  16. DUNN MG, Lessa FC, Sanchez J, Cordero R, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic.
    J Infect Dis. 2021;224.
    >> Share

  17. SAHA S, Saha SK
    Invasive Bacterial Vaccine-Preventable Disease Surveillance: Successes and Lessons Learned in Bangladesh for a Sustainable Path Forward.
    J Infect Dis. 2021;224.
    >> Share

    August 2021
  18. HOLMGREN J
    Modern History of Cholera Vaccines and the Pivotal Role of icddr,b.
    J Infect Dis. 2021 Aug 28. pii: 6359024. doi: 10.1093.
    >> Share

  19. LINNIK J, Syedbasha M, Kaltenbach HM, Vogt D, et al
    Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant (HSCT) patients.
    J Infect Dis. 2021 Aug 20. pii: 6355382. doi: 10.1093.
    >> Share

  20. DE MIGUEL BUCKLEY R, Diaz-Menendez M, Garcia-Rodriguez J, Arribas JR, et al
    Seasonal coronavirus pneumonia after SARS-Cov-2 infection and vaccine: new frenemies?
    J Infect Dis. 2021 Aug 20. pii: 6355378. doi: 10.1093.
    >> Share

  21. NATHAN N, Prevost B, Lambert S, Schnuriger A, et al
    SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents.
    J Infect Dis. 2021 Aug 19. pii: 6354728. doi: 10.1093.
    >> Share

  22. YANG CY, Lee YY, Wei JC
    Interpreting prevention of COVID-19 and vaccines.
    J Infect Dis. 2021 Aug 18. pii: 6354219. doi: 10.1093.
    >> Share

  23. CONNOLLY KL, Pilligua-Lucas M, Gomez C, Costenoble-Caherty AC, et al
    Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.
    J Infect Dis. 2021;224.
    >> Share

  24. SHAKYA M, Neuzil KM, Pollard AJ
    Prospects of future typhoid and paratyphoid vaccines in endemic countries.
    J Infect Dis. 2021 Aug 10. pii: 6347515. doi: 10.1093.
    >> Share

  25. BURKE RM, Tate JE, Parashar UD
    Global Experience with Rotavirus Vaccines.
    J Infect Dis. 2021 Aug 10. pii: 6347290. doi: 10.1093.
    >> Share

  26. SARKER P, Mily A, Ara A, Haque F, et al
    Functional antibodies and innate immune responses to WRSS1, a live oral Shigella sonnei vaccine candidate in Bangladeshi adults and children.
    J Infect Dis. 2021 Aug 10. pii: 6347306. doi: 10.1093.
    >> Share

  27. CHANG KC, Chang MH, Chen HL, Wu JF, et al
    Universal Infant Hepatitis B Virus (HBV) Vaccination for 35 years: moving toward the Eradication of HBV.
    J Infect Dis. 2021 Aug 7. pii: 6345224. doi: 10.1093.
    >> Share

    July 2021
  28. EIDEN J, Volckaert B, Rudenko O, Aitchison R, et al
    Single Replication M2SR Influenza Vaccine Induced Immune Responses Associated with Protection Against Human Challenge with Highly Drifted H3N2 Influenza Strain.
    J Infect Dis. 2021 Jul 29. pii: 6330582. doi: 10.1093.
    >> Share

  29. WINER RL, Lin J, Querec TD, Unger ER, et al
    Effectiveness Of Human Papillomavirus (HPV) Vaccination Against Penile Hpv Infection In Men Who Have Sex With Men And Transgender Women.
    J Infect Dis. 2021 Jul 28. pii: 6329629. doi: 10.1093.
    >> Share

  30. DEEN J, Clemens JD
    Assessment of vaccine herd protection: Lessons learned from cholera and typhoid vaccine trials.
    J Infect Dis. 2021 Jul 17. pii: 6323356. doi: 10.1093.
    >> Share

  31. PETRIE JG, Bazzi LA, McDermott AB, Follmann D, et al
    Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    J Infect Dis. 2021;224:49-59.
    >> Share

  32. GIACOMELLI CAO R, Christian L, Xu Z, Jaramillo L, et al
    Early changes in interferon gene expression and antibody responses following influenza vaccination in pregnant women.
    J Infect Dis. 2021 Jul 1. pii: 6312681. doi: 10.1093.
    >> Share

    June 2021
  33. HUANG Y, Williamson BD, Moodie Z, Carpp LN, et al
    Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials.
    J Infect Dis. 2021 Jun 26. pii: 6310132. doi: 10.1093.
    >> Share

  34. VAHLE K, Gargano JW, Lewis RM, Querec TD, et al
    Prevalence of human papillomavirus among females older than recommended age for vaccination by birth cohort, United States 20032016.
    J Infect Dis. 2021 Jun 23. pii: 6308446. doi: 10.1093.
    >> Share

  35. SCHWARZ TF, Johnson C, Grigat C, Apter D, et al
    Three dose levels of a maternal respiratory syncytial virus vaccine candidate are well tolerated and immunogenic in a randomized trial in non-pregnant women.
    J Infect Dis. 2021 Jun 19. pii: 6306104. doi: 10.1093.
    >> Share

  36. MESSINA NL, Pittet LF, Gardiner K, Freyne B, et al
    Neonatal BCG vaccination and infections in the first year of life: the MIS BAIR randomised controlled trial.
    J Infect Dis. 2021 Jun 19. pii: 6306399. doi: 10.1093.
    >> Share

  37. MA Y, Liu F, Lin T, Chen L, et al
    Large-scale identification of T cell epitopes derived from SARS-CoV-2 for the development of peptide vaccines against COVID-19.
    J Infect Dis. 2021 Jun 18. pii: 6305142. doi: 10.1093.
    >> Share

  38. BRINKMAN ID, Butler AL, de Wit J, van Binnendijk RS, et al
    Measles vaccination elicits a polyfunctional antibody response, which decays more rapidly in early vaccinated children.
    J Infect Dis. 2021 Jun 16. pii: 6301139. doi: 10.1093.
    >> Share

  39. DEMONBREUN AR, Sancilio A, Velez ME, Ryan DT, et al
    COVID-19 mRNA vaccination generates greater IgG levels in women compared to men.
    J Infect Dis. 2021 Jun 12. pii: 6297423. doi: 10.1093.
    >> Share

    May 2021
  40. MAHON BE, Simon J, Widdowson MA, Samai M, et al
    Baseline Asymptomatic Malaria Infection and Immunogenicity of rVSVDeltaG-ZEBOV-GP Vaccine: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2021 May 20. pii: 6278485. doi: 10.1093.
    >> Share

  41. FELDSTEIN LR, Ferdinands JM, Self WH, Randolph AG, et al
    Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates.
    J Infect Dis. 2021 May 20. pii: 6278475. doi: 10.1093.
    >> Share

  42. JOFFE S, Babiker A, Ellenberg SS, Fix A, et al
    Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
    J Infect Dis. 2021 May 19. pii: 6278127. doi: 10.1093.
    >> Share

  43. BIANCHI FP, Germinario CA, Migliore G, Vimercati L, et al
    BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report.
    J Infect Dis. 2021 May 19. pii: 6278131. doi: 10.1093.
    >> Share

  44. COREY L
    Behind the Scenes Heroes: the COVID-19 Vaccine Data and Safety Monitoring Board.
    J Infect Dis. 2021 May 19. pii: 6278073. doi: 10.1093.
    >> Share

  45. HOES J, King AJ, Schurink-van 't Klooster TM, Berkhof PJ, et al
    Vaccine effectiveness following routine immunization with bivalent HPV vaccine: Protection against incident genital HPV infections from a reduced-dosing schedule.
    J Infect Dis. 2021 May 8. pii: 6272563. doi: 10.1093.
    >> Share

  46. BURGOMASTER KE, Foreman BM, Aleshnick MA, Larman BC, et al
    Limited flavivirus cross-reactive antibody responses elicited by a ZIKV DNA vaccine candidate in humans.
    J Infect Dis. 2021 May 7. pii: 6271521. doi: 10.1093.
    >> Share

  47. BARTSCH SM, Wedlock PT, O'Shea KJ, Cox SN, et al
    Lives and Costs Saved by Expanding and Expediting COVID-19 Vaccination.
    J Infect Dis. 2021 May 6. pii: 6267841. doi: 10.1093.
    >> Share

    April 2021
  48. GONZALEZ HC, Trudeau S, Gordon SC
    Editorial: Changing trends in the US prevalence of hepatitis B core antibody provide important perspectives into future screening and vaccination strategies.
    J Infect Dis. 2021 Apr 27. pii: 6254533. doi: 10.1093.
    >> Share

  49. FERNANDEZ J, Sanders H, Henn J, Wilson JM, et al
    Vaccination with Detoxified Leukocidin AB Reduces Bacterial Load in a Staphylococcus aureus Minipig Deep Surgical Wound Infection Model.
    J Infect Dis. 2021 Apr 25. pii: 6251738. doi: 10.1093.
    >> Share

  50. SCHALTZ-BUCHHOLZER F, Aaby P, Monteiro I, Camala L, et al
    Immediate Bacille Calmette-Guerin vaccination to neonates requiring perinatal treatment at the maternity ward in Guinea-Bissau: A randomized controlled trial.
    J Infect Dis. 2021 Apr 24. pii: 6249562. doi: 10.1093.
    >> Share

  51. KALKOWSKA DA, Pallansch MA, Cochi SL, Thompson KM, et al
    Updated characterization of poliovirus transmission in Pakistan and Afghanistan and the impacts of different outbreak response vaccine options.
    J Infect Dis. 2021 Apr 22. pii: 6246102. doi: 10.1093.
    >> Share

  52. SPINOLA SM, Zimet GD, Ott MA, Katz BP, et al
    Corrigendum to: Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure due to Ethical and Practical Issues.
    J Infect Dis. 2021 Apr 19. pii: 6226582. doi: 10.1093.
    >> Share

  53. EL SAHLY HM, Atmar RL, Sendra E, Wegel A, et al
    Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults.
    J Infect Dis. 2021 Apr 14. pii: 6225864. doi: 10.1093.
    >> Share

  54. ESONA MD, Ward ML, Wikswo ME, Rustempasic SM, et al
    Rotavirus Genotype Trends and Gastrointestinal Pathogen Detection in the United States, 2014-16: Results from the New Vaccine Surveillance Network.
    J Infect Dis. 2021 Apr 2. pii: 6209394. doi: 10.1093.
    >> Share

    March 2021
  55. WANG K, Dropulic L, Bozekowski J, Pietz HL, et al
    Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine.
    J Infect Dis. 2021 Mar 15. pii: 6170962. doi: 10.1093.
    >> Share

  56. LEWNARD JA, Bruxvoort KJ, Fischer H, Hong VX, et al
    Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract.
    J Infect Dis. 2021 Mar 9. pii: 6164926. doi: 10.1093.
    >> Share

  57. FREY SE, Stapleton JT, Ballas ZK, Rasmussen WL, et al
    Human antibody responses following vaccinia immunization using protein microarrays and correlation with cell-mediated and antibody dependent cellular cytotoxicity responses.
    J Infect Dis. 2021 Mar 1. pii: 6155758. doi: 10.1093.
    >> Share

    February 2021
  58. WU HW, Park S, Pond-Tor S, Stuart R, et al
    Whole-proteome differential screening identifies novel vaccine candidates for schistosomiasis japonica.
    J Infect Dis. 2021 Feb 19. pii: 6133347. doi: 10.1093.
    >> Share

  59. KASEKE C, Tano-Menka R, Senjobe F, Gaiha GD, et al
    The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.
    J Infect Dis. 2021;223.
    >> Share

  60. BEHR MA, Divangahi M, Schurr E
    Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
    J Infect Dis. 2021;223:189-191.
    >> Share

  61. TSUJI I, Dominguez D, Egan MA, Dean HJ, et al
    Development of a novel assay to assess the avidity of dengue virus-specific antibodies elicited in response to a tetravalent dengue vaccine.
    J Infect Dis. 2021 Feb 3. pii: 6127289. doi: 10.1093.
    >> Share

  62. ENDY TP, Wang D, Polhemus ME, Jarman RG, et al
    A Phase 1, Open-Label Assessment of a Dengue Virus-1 Live Virus Human Challenge Strain.
    J Infect Dis. 2021;223:258-267.
    >> Share

    January 2021
  63. DE PIJPER CA, Langedijk AC, Terryn S, Van Gucht S, et al
    Long-term memory response after a single intramuscular rabies booster vaccination, 10-24 years after primary immunization.
    J Infect Dis. 2021 Jan 27. pii: 6121364. doi: 10.1093.
    >> Share

  64. KURUP D, Fisher CR, Scher G, Yankowski C, et al
    Tetravalent rabies-vectored Filovirus and Lassa fever vaccine induces long-term immunity in nonhuman primates.
    J Infect Dis. 2021 Jan 9. pii: 6075344. doi: 10.1093.
    >> Share

  65. FAN X, Li N, Xu M, Yang D, et al
    Intrapulmonary Vaccination Induces Long-lasting and Effective Pulmonary Immunity against Staphylococcus aureus Pneumonia.
    J Infect Dis. 2021 Jan 8. pii: 6071502. doi: 10.1093.
    >> Share

    December 2020
  66. TENFORDE MW, Talbot HK, Trabue CH, Gaglani M, et al
    Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.
    J Infect Dis. 2020 Dec 30. pii: 6055595. doi: 10.1093.
    >> Share

  67. BRICKLEY EB, Connor RI, Wieland-Alter W, Weiner JA, et al
    Intestinal antibody responses to two novel live attenuated type 2 oral poliovirus vaccines in healthy adults in Belgium.
    J Infect Dis. 2020 Dec 24. pii: 6046404. doi: 10.1093.
    >> Share

  68. KUBALE J, Balmaseda A, Sanchez N, Lopez R, et al
    Pneumonia following symptomatic influenza infection among Nicaraguan children before and after introduction of the pneumococcal conjugate vaccine.
    J Infect Dis. 2020 Dec 22. pii: 6044070. doi: 10.1093.
    >> Share

  69. CAPEDING MR, Gomez-Go GD, Oberdorfer P, Borja-Tabora C, et al
    Safety and immunogenicity of a new inactivated polio vaccine made from Sabin strains: a randomized, double-blind, active-controlled, phase 2/3 seamless study.
    J Infect Dis. 2020 Dec 22. pii: 6044221. doi: 10.1093.
    >> Share

  70. KIMBALL J, Zhu Y, Wyatt D, Trabue CH, et al
    Influenza Vaccine Failure Associated with Age and Immunosuppression.
    J Infect Dis. 2020 Dec 19. pii: 6041867. doi: 10.1093.
    >> Share

  71. FERDINANDS JM, Gaglani M, Ghamande S, Martin ET, et al
    Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
    J Infect Dis. 2020 Dec 18. pii: 6041424. doi: 10.1093.
    >> Share

  72. SIERRA MS, Tsang SH, Hu S, Porras C, et al
    Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT).
    J Infect Dis. 2020 Dec 16. pii: 6039229. doi: 10.1093.
    >> Share

  73. LOPEZ-MEDINA E, Biswal S, Saez-Llorens X, Borja-Tabora C, et al
    Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination.
    J Infect Dis. 2020 Dec 15. pii: 6034203. doi: 10.1093.
    >> Share

    November 2020
  74. BEHR MA, Divangahi M, Schurr E
    Lessons from BCG for SARS-CoV-2 vaccine candidates.
    J Infect Dis. 2020 Nov 30. pii: 6012502. doi: 10.1093.
    >> Share

  75. CLEMENS EA, Holbrook BC, Kanekiyo M, Yewdell JW, et al
    An R848 conjugated influenza virus vaccine elicits robust IgG to hemagglutinin stem in a newborn nonhuman primate model.
    J Infect Dis. 2020 Nov 27. pii: 6007684. doi: 10.1093.
    >> Share

  76. TAGBO BN, Verma H, Mahmud ZM, Ernest K, et al
    Randomized Controlled Clinical Trial of bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children.
    J Infect Dis. 2020 Nov 24. pii: 5999481. doi: 10.1093.
    >> Share

  77. CHLIBEK R, Bayas JM, Collins H, de la Pinta MLR, et al
    Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >/=50 Years of Age.
    J Infect Dis. 2020 Nov 20. pii: 5993994. doi: 10.1093.
    >> Share

  78. PAYNE DC, McNeal M, Staat MA, Piasecki AM, et al
    Maternal Anti-Rotavirus IgG Antibodies Persist in the Post-Rotavirus Vaccine Era.
    J Infect Dis. 2020 Nov 19. pii: 5992213. doi: 10.1093.
    >> Share

  79. LAAKE I, Feiring B, Jonassen CM, Pettersson JH, et al
    Concurrent infection with multiple human papillomavirus types among unvaccinated and vaccinated 17-year-old Norwegian girls.
    J Infect Dis. 2020 Nov 17. pii: 5986714. doi: 10.1093.
    >> Share

  80. DE DEUS N, Capitine IPU, Bauhofer AFL, Marques S, et al
    Immunogenicity of reduced-dose monovalent type 2 oral poliovirus vaccine in Mocuba, Mozambique.
    J Infect Dis. 2020 Nov 12. pii: 5979486. doi: 10.1093.
    >> Share

  81. MARTIN ET, Cheng C, Petrie JG, Alyanak E, et al
    Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    J Infect Dis. 2020 Nov 3. pii: 5952469. doi: 10.1093.
    >> Share

  82. SALMON DA, Dudley MZ, Carleton BC
    Guillain-Barre Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.
    J Infect Dis. 2020 Nov 2. pii: 5952166. doi: 10.1093.
    >> Share

  83. PEREZ-VILAR S, Hu M, Weintraub E, Arya D, et al
    Guillain-Barre Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
    J Infect Dis. 2020 Nov 2. pii: 5952165. doi: 10.1093.
    >> Share

    October 2020
  84. HANIFI SMA, Fisker AB, Welaga P, Rieckmann A, et al
    Diphtheria-tetanus-pertussis (DTP) vaccine is associated with increased female-male mortality rate ratios. A meta-analysis of studies of DTP administered before and after measles vaccine.
    J Infect Dis. 2020 Oct 30. pii: 5944053. doi: 10.1093.
    >> Share

  85. HINOJOSA M, Shepard SS, Chung JR, King JP, et al
    Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
    J Infect Dis. 2020 Oct 22. pii: 5934948. doi: 10.1093.
    >> Share

  86. SHANNON I, White CL, Yang H, Nayak JL, et al
    Differences in influenza-specific CD4 T cell mediated immunity following acute infection versus inactivated vaccination in children.
    J Infect Dis. 2020 Oct 19. pii: 5930368. doi: 10.1093.
    >> Share

  87. MESALAM AA
    Hepatitis C virus vaccine development: A step forward.
    J Infect Dis. 2020 Oct 11. pii: 5920711. doi: 10.1093.
    >> Share

  88. MHANGO C, Mandolo JJ, Chinyama E, Wachepa R, et al
    Rotavirus Genotypes in Hospitalized Children with Acute Gastroenteritis Before and After Rotavirus Vaccine Introduction in Blantyre, Malawi, 1997 - 2019.
    J Infect Dis. 2020 Oct 9. pii: 5919783. doi: 10.1093.
    >> Share

  89. COX KS, Zhang L, Freed DC, Tang A, et al
    Functional Evaluation and Genetic Evolution of Human T-cell Responses after Vaccination with a Conditionally Replication-Defective Cytomegalovirus Vaccine.
    J Infect Dis. 2020 Oct 8. pii: 5919748. doi: 10.1093.
    >> Share

  90. MILLER M
    Establishing the Value and Strategies for Respiratory Syncytial Virus (RSV) Control: The European RSV Consortium (RESCEU).
    J Infect Dis. 2020;222.
    >> Share

  91. WILDENBEEST JG, Zuurbier RP, Korsten K, van Houten MA, et al
    Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
    J Infect Dis. 2020;222.
    >> Share

  92. CHUNG A, Reeves RM, Nair H, Campbell H, et al
    Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study.
    J Infect Dis. 2020;222.
    >> Share

  93. KANN H, Lehtinen M, Eriksson T, Surcel HM, et al
    Sustained Cross-Reactive Antibody Responses After Human Papillomavirus Vaccinations: Up To 12 Years Follow-Up In The Finnish Maternity Cohort.
    J Infect Dis. 2020 Oct 3. pii: 5917504. doi: 10.1093.
    >> Share

  94. EYAL N, Lipsitch M, Smith PG
    Reply to Hasford and to Spinola et al.
    J Infect Dis. 2020;222:1574-1575.
    >> Share

    September 2020
  95. FRIEDMAN-KLABANOFF DJ, Travassos MA, Ifeonu OO, Agrawal S, et al
    Epitope-specific antibody responses to a Plasmodium falciparum subunit vaccine target in a malaria-endemic population.
    J Infect Dis. 2020 Sep 29. pii: 5913015. doi: 10.1093.
    >> Share

  96. LIN L, Koren MA, Paolino KM, Eckels KH, et al
    Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase I Randomized Clinical Trial.
    J Infect Dis. 2020 Sep 23. pii: 5910633. doi: 10.1093.
    >> Share

  97. GOLDSTEIN N, Bockstal V, Bart S, Luhn K, et al
    Safety and Immunogenicity of Heterologous and Homologous Two Dose Regimens of Ad26- and MVA-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study.
    J Infect Dis. 2020 Sep 16. pii: 5906668. doi: 10.1093.
    >> Share

  98. ZIMMERMAN RK, South-Paul JE, Poland GA
    Rationing of civilian COVID-19 vaccines while supplies are limited.
    J Infect Dis. 2020 Sep 7. pii: 5902567. doi: 10.1093.
    >> Share

  99. NALIN D
    Immunosenescence and SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 Sep 5. pii: 5901694. doi: 10.1093.
    >> Share

  100. TOTA JE, Struyf F, Hildesheim A, Gonzalez P, et al
    Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials.
    J Infect Dis. 2020 Sep 5. pii: 5901687. doi: 10.1093.
    >> Share

  101. BLUMENFELD O, Hampe CS, Shulman LM, Chen R, et al
    An Attenuation in the Incidence of Early Childhood Diabetes Correlates With Introduction of Rotavirus Vaccination in Israel.
    J Infect Dis. 2020 Sep 1. pii: 5900392. doi: 10.1093.
    >> Share

  102. BURKE RM, Tate JE, Jiang B, Parashar UD, et al
    Rotavirus and Type 1 Diabetes-Is There a Connection? A Synthesis of the Evidence.
    J Infect Dis. 2020;222:1076-1083.
    >> Share

  103. PATEL MK, Antoni S, Nedelec Y, Sodha S, et al
    The Changing Global Epidemiology of Measles, 2013-2018.
    J Infect Dis. 2020;222:1117-1128.
    >> Share

    August 2020
  104. WILHELM M, Kaur A, Wernli M, Hirsch HH, et al
    BK Polyomavirus (BKPyV)-specific CD8 T-cell expansion in vitro using 27mer peptide antigens for developing adoptive T-cell transfer and vaccination.
    J Infect Dis. 2020 Aug 28. pii: 5898575. doi: 10.1093.
    >> Share

  105. SADOFF J, De Paepe E, Haazen W, Omoruyi E, et al
    Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
    J Infect Dis. 2020 Aug 26. pii: 5897745. doi: 10.1093.
    >> Share

  106. HASFORD J
    Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.
    J Infect Dis. 2020 Aug 26. pii: 5897422. doi: 10.1093.
    >> Share

  107. SPINOLA SM, Zimet GD, Ott MA, Katz BP, et al
    Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure Due to Ethical and Practical Issues.
    J Infect Dis. 2020 Aug 26. pii: 5897421. doi: 10.1093.
    >> Share

  108. VAN BOVEN M, Teirlinck AC, Meijer A, Hooiveld M, et al
    Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination.
    J Infect Dis. 2020 Aug 21. pii: 5895295. doi: 10.1093.
    >> Share

  109. SALEEM AF, Mach O, Yousafzai MT, Kazi Z, et al
    One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine.
    J Infect Dis. 2020 Aug 15. pii: 5892949. doi: 10.1093.
    >> Share

  110. BEALL B, Walker H, Tran T, Li Z, et al
    Upsurge of conjugate vaccine serotype 4 invasive pneumococcal disease clusters among adults experiencing homelessness in California, Colorado, and New Mexico.
    J Infect Dis. 2020 Aug 15. pii: 5892947. doi: 10.1093.
    >> Share

  111. HALSTEAD SB, Katzelnick L
    COVID 19 Vaccines: Should we fear ADE?
    J Infect Dis. 2020 Aug 12. pii: 5891764. doi: 10.1093.
    >> Share

  112. RAMAN R, Brennan J, Ndi D, Sloan C, et al
    Marked Reduction of Socioeconomic and Racial Disparities in Invasive Pneumococcal Disease Associated with Conjugate Pneumococcal Vaccines.
    J Infect Dis. 2020 Aug 11. pii: 5891230. doi: 10.1093.
    >> Share

  113. PANG Y, Wang Q, Lv M, Yu M, et al
    Influenza vaccination protects against hospitalization outcomes among older patients with cardiovascular or respiratory diseases.
    J Infect Dis. 2020 Aug 11. pii: 5890841. doi: 10.1093.
    >> Share

    July 2020
  114. JORDAN E, Lawrence SJ, Meyer TPH, Schmidt D, et al
    Broad Antibody and Cellular Immune Response from a Phase 2 Clinical Trial with a Novel Multivalent Poxvirus Based RSV Vaccine.
    J Infect Dis. 2020 Jul 29. pii: 5878073. doi: 10.1093.
    >> Share

  115. MCCALL MBB, Yap XZ, Bousema T
    Optimizing RTS,S vaccination strategies: give it your best parting shot.
    J Infect Dis. 2020 Jul 20. pii: 5873653. doi: 10.1093.
    >> Share

  116. SIRIVICHAYAKUL C, Barranco-Santana EA, Rivera IE, Kilbury J, et al
    Long-term safety and immunogenicity of a tetravalent dengue vaccine candidate in children and adults: a randomized, placebo-controlled, phase 2 study.
    J Infect Dis. 2020 Jul 13. pii: 5870825. doi: 10.1093.
    >> Share

  117. SCHLOM J, Donahue RN
    Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.
    J Infect Dis. 2020 Jul 11. pii: 5870046. doi: 10.1093.
    >> Share

  118. DAWSON L, Earl J, Livezey J
    Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
    J Infect Dis. 2020;222:514-516.
    >> Share

  119. EYAL N, Lipsitch M, Smith PG
    Response to Dawson et al.
    J Infect Dis. 2020;222:516-517.
    >> Share

  120. COCHI SL, Pallansch MA
    The Long and Winding Road to Eradicate Vaccine-Related Polioviruses.
    J Infect Dis. 2020 Jul 5. pii: 5867495. doi: 10.1093.
    >> Share

  121. YAN D, Wang D, Zhang Y, Li X, et al
    Implication of a High Risk of Type 2 Vaccine-Derived Poliovirus Emergence and Transmission after the Switch from tOPV to bOPV.
    J Infect Dis. 2020 Jul 4. pii: 5867493. doi: 10.1093.
    >> Share

  122. BANDYOPADHYAY AS, Gast C, Brickley EB, Ruttimann R, et al
    A randomized phase 4 study of immunogenicity and safety following monovalent oral type 2 Sabin polio vaccine challenge in IPV-vaccinated children in Lithuania.
    J Infect Dis. 2020 Jul 4. pii: 5867494. doi: 10.1093.
    >> Share

  123. HU SY, Tsang SH, Chen F, Pan QJ, et al
    Association between Common Vaginal Infections and Cervical Non-HPV16/18 Infection in HPV-Vaccinated Women.
    J Infect Dis. 2020 Jul 2. pii: 5866538. doi: 10.1093.
    >> Share

    June 2020
  124. MICHLMAYR D, Andrade P, Nascimento EJM, Parker A, et al
    Characterization of the type-specific and cross-reactive B cell responses elicited by a live-attenuated tetravalent dengue vaccine.
    J Infect Dis. 2020 Jun 23. pii: 5861003. doi: 10.1093.
    >> Share

  125. EYAL N, Lipsitch M, Smith PG
    Response to Cioffi.
    J Infect Dis. 2020;222:169-170.
    >> Share

  126. NDEFFO-MBAH ML, Pandey A
    Global Risk and Elimination of Yellow Fever Epidemics.
    J Infect Dis. 2020;221:2026-2034.
    >> Share

  127. MEITES E, Winer RL, Newcomb ME, Gorbach PM, et al
    Vaccine effectiveness on DNA prevalence of human papillomavirus infection in anal and oral specimens from men who have sex with men- United States, 2016-2018.
    J Infect Dis. 2020 Jun 6. pii: 5854104. doi: 10.1093.
    >> Share

  128. HASTIE A, Catteau G, Enemuo A, Mrkvan T, et al
    Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination.
    J Infect Dis. 2020 Jun 5. pii: 5851921. doi: 10.1093.
    >> Share

  129. URSIN RL, Liu H, Powell HR, Westerbeck J, et al
    Differential antibody recognition of H3N2 vaccine and seasonal influenza virus strains based on age, vaccine status, and sex in the 2017-18 season.
    J Infect Dis. 2020 Jun 4. pii: 5851359. doi: 10.1093.
    >> Share

  130. CHARLTON B, Hockley J, Laassri M, Wilton T, et al
    The use of next generation sequencing for the quality control of live-attenuated polio vaccines.
    J Infect Dis. 2020 Jun 3. pii: 5850979. doi: 10.1093.
    >> Share

  131. SINGH JA
    The case for why Africa should host COVID-19 candidate vaccine trials.
    J Infect Dis. 2020 Jun 3. pii: 5850913. doi: 10.1093.
    >> Share

  132. KANG CK, Kim HR, Song KH, Keam B, et al
    Cell-Mediated Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
    J Infect Dis. 2020 Jun 1. pii: 5849850. doi: 10.1093.
    >> Share

    May 2020
  133. COWLING BJ, Thompson MG, Ng TWY, Fang VJ, et al
    Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
    J Infect Dis. 2020 May 14. pii: 5837136. doi: 10.1093.
    >> Share

  134. TCHALLA EYI, Bhalla M, Wohlfert EA, Bou Ghanem EN, et al
    Neutrophils are required during immunization with the pneumococcal conjugate vaccine for protective antibody responses and host defense against infection.
    J Infect Dis. 2020 May 11. pii: 5835638. doi: 10.1093.
    >> Share

  135. BARTSCH SM, Mitgang EA, Geller G, Cox SN, et al
    What if the Influenza Vaccine Did Not Offer Such Variable Protection?
    J Infect Dis. 2020 May 9. pii: 5835317. doi: 10.1093.
    >> Share

  136. YUILL S, Egger S, Smith M, Velentzis L, et al
    Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia.
    J Infect Dis. 2020 May 9. pii: 5827184. doi: 10.1093.
    >> Share

  137. GRAEPEL KW, Kochhar S, Clayton EW, Edwards KE, et al
    Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 May 4. pii: 5828933. doi: 10.1093.
    >> Share

  138. SALAMANCA DE LA CUEVA I, Pahud B, Huang LM, Leonardi M, et al
    Immunogenicity and safety of porcine circovirus-free human rotavirus vaccine in healthy infants: a phase III, randomized trial.
    J Infect Dis. 2020 May 4. pii: 5829005. doi: 10.1093.
    >> Share

    April 2020
  139. CIOFFI A
    COVID-19: Is Everything Appropriate to Create an Effective Vaccine?
    J Infect Dis. 2020 Apr 29. pii: 5826955. doi: 10.1093.
    >> Share

  140. BOLOTIN S, Hughes SL, Gul N, Khan S, et al
    What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic Review.
    J Infect Dis. 2020;221:1576-1583.
    >> Share

  141. WILLIAMS K, Bastian AR, Feldman RA, Omoruyi E, et al
    Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine with an Adenovirus 26 Vector Encoding Pre-Fusion F (Ad26.RSV.preF) in adults 60 years and older.
    J Infect Dis. 2020 Apr 22. pii: 5823828. doi: 10.1093.
    >> Share

  142. SCHWENDINGER M, Thiry G, De Vos B, Leroux-Roels G, et al
    A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus.
    J Infect Dis. 2020 Apr 21. pii: 5821369. doi: 10.1093.
    >> Share

  143. MOHN KG, Brokstad KA, Islam S, Oftung F, et al
    Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    J Infect Dis. 2020;221:1528-1537.
    >> Share

  144. BURNETT E, Kabir F, Van Trang N, Rayamajhi A, et al
    Infectious Etiologies of Intussusception Among Children <2 Years Old in 4 Asian Countries.
    J Infect Dis. 2020;221:1499-1505.
    >> Share

    March 2020
  145. KURTOVIC L, Atre T, Feng G, Wines BD, et al
    Multi-functional antibodies are induced by the RTS,S malaria vaccine and associated with protection in a phase I/IIa trial.
    J Infect Dis. 2020 Mar 31. pii: 5814271. doi: 10.1093.
    >> Share

  146. EYAL N, Lipsitch M, Smith PG
    Human challenge studies to accelerate coronavirus vaccine licensure.
    J Infect Dis. 2020 Mar 31. pii: 5814216. doi: 10.1093.
    >> Share

  147. SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
    Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.
    J Infect Dis. 2020 Mar 26. pii: 5811682. doi: 10.1093.
    >> Share

  148. KAUSHAL D
    The Comeback Kid: BCG.
    J Infect Dis. 2020;221:1031-1032.
    >> Share

  149. DE SANJOSE S, Bruni L
    Is it now the time to plan for global gender-neutral vaccination?
    J Infect Dis. 2020 Mar 11. pii: 5803244. doi: 10.1093.
    >> Share

  150. VANSKA S, Luostarinen T, Bausssano I, Apter D, et al
    Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied.
    J Infect Dis. 2020 Mar 11. pii: 5803245. doi: 10.1093.
    >> Share

  151. WILLIAMS FB, Kader A, Colgate ER, Dickson DM, et al
    Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh.
    J Infect Dis. 2020 Mar 11. pii: 5802696. doi: 10.1093.
    >> Share

  152. GRIFFITHS P, Hughes B
    Choice of Study Populations for Vaccines.
    J Infect Dis. 2020;221.
    >> Share

  153. KRAUSE PR, Roberts J
    Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines.
    J Infect Dis. 2020;221.
    >> Share

  154. ROARK HK, Jenks JA, Permar SR, Schleiss MR, et al
    Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.
    J Infect Dis. 2020;221.
    >> Share

  155. PLOTKIN SA, Wang D, Oualim A, Diamond DJ, et al
    The Status of Vaccine Development Against the Human Cytomegalovirus.
    J Infect Dis. 2020;221.
    >> Share

  156. LANZIERI TM, Gastanaduy PA, Gambhir M, Plotkin SA, et al
    Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection.
    J Infect Dis. 2020;221.
    >> Share

  157. HAIDAR G, Boeckh M, Singh N
    Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.
    J Infect Dis. 2020;221.
    >> Share

  158. PLOTKIN SA
    Preventing Infection by Human Cytomegalovirus.
    J Infect Dis. 2020;221.
    >> Share

  159. NELSON CS, Baraniak I, Lilleri D, Reeves MB, et al
    Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.
    J Infect Dis. 2020;221.
    >> Share

  160. GRAHAM JB, Swarts JL, Menachery VD, Gralinski LE, et al
    Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
    J Infect Dis. 2020;221:882-889.
    >> Share

  161. HALSTEAD SB, Russell PK, Brandt WE
    NS1, Dengue's Dagger.
    J Infect Dis. 2020;221:857-860.
    >> Share

    February 2020
  162. DAGNEW AF, Klein NP, Herve C, Kalema G, et al
    The Adjuvanted Recombinant Zoster Vaccine in Adults Aged >/=65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine.
    J Infect Dis. 2020 Feb 27. pii: 5760710. doi: 10.1093.
    >> Share

  163. IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
    Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19.
    J Infect Dis. 2020 Feb 26. pii: 5758057. doi: 10.1093.
    >> Share

  164. BURNETT E, Parashar UD, Tate JE
    Global impact of rotavirus vaccination on diarrhea hospitalizations and deaths among children <5 years old: 2006-2019.
    J Infect Dis. 2020 Feb 25. pii: 5755890. doi: 10.1093.
    >> Share

  165. ATMAR RL, Ettayebi K, Ayyar BV, Neill FH, et al
    Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection.
    J Infect Dis. 2020;221:739-743.
    >> Share

  166. FAINGELERNT Y, Dagan R, Givon-Lavi N, Ben-Shimol S, et al
    Nasopharyngeal Carriage of Invasive Pneumococcal Serotypes During Childhood Community-Acquired Alveolar Pneumonia Is Associated With Specific Clinical Presentation.
    J Infect Dis. 2020;221:812-819.
    >> Share

  167. BAUTISTA-GOGEL J, Madsen CM, Lu X, Sakthivel SK, et al
    Outbreak of Respiratory Illness Associated With Human Adenovirus Type 7 Among Persons Attending Officer Candidates School, Quantico, Virginia, 2017.
    J Infect Dis. 2020;221:697-700.
    >> Share

  168. BAKER JM, Tate JE, Leon J, Haber MJ, et al
    Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings.
    J Infect Dis. 2020 Feb 15. pii: 5736407. doi: 10.1093.
    >> Share

  169. EISINGER RW, Embry AC, Read SW, Fauci AS, et al
    2019: A Banner Year for Tuberculosis Research.
    J Infect Dis. 2020 Feb 11. pii: 5719366. doi: 10.1093.
    >> Share

  170. ZIMMERMANN M, Hagedorn B, Lyons H
    Projection of Costs of Polio Eradication Compared to Permanent Control.
    J Infect Dis. 2020;221:561-565.
    >> Share

  171. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children.
    J Infect Dis. 2020 Feb 1. pii: 5719572. doi: 10.1093.
    >> Share

    January 2020
  172. MARAVELIA P, Frelin L, Ni Y, Perez NC, et al
    Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections.
    J Infect Dis. 2020 Jan 29. pii: 5717223. doi: 10.1093.
    >> Share

  173. FREYNE B, Messina NL, Donath S, Germano S, et al
    Neonatal BCG vaccination reduces interferon gamma responsiveness to heterologous pathogens in infants from a randomised controlled trial.
    J Infect Dis. 2020 Jan 28. pii: 5716732. doi: 10.1093.
    >> Share

  174. HOES J, Pasmans H, Knol MJ, Donken R, et al
    Persisting Antibody Response Nine Years after Bivalent HPV Vaccination in A Cohort of Dutch Women: Immune Response and the Relation with Genital HPV Infections.
    J Infect Dis. 2020 Jan 9. pii: 5698719. doi: 10.1093.
    >> Share

    December 2019
  175. NILSSON A, Chiodi F
    Early antiretroviral therapy may preserve vaccine responses in HIV infected patients by preventing damage to long-lived plasma cells.
    J Infect Dis. 2019 Dec 23. pii: 5684907. doi: 10.1093.
    >> Share

  176. THOMAS A, Hammarlund E, Gao L, Holman S, et al
    Loss of Pre-Existing Immunological Memory among HIV Infected Women Despite Immune Reconstitution with Antiretroviral Therapy.
    J Infect Dis. 2019 Dec 23. pii: 5684906. doi: 10.1093.
    >> Share

  177. VADREVU KM, Potula V, Khalatkar V, Mahantshetty NS, et al
    Persistence of Immune responses with an Inactivated Japanese Encephalitis single-dose vaccine JENVAC(R) and interchangeability with a live-attenuated vaccine.
    J Infect Dis. 2019 Dec 20. pii: 5681576. doi: 10.1093.
    >> Share

  178. BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
    Duration and Density of Fecal Rotavirus Shedding in Vaccinated Malawian Children With Rotavirus Gastroenteritis.
    J Infect Dis. 2019 Dec 13. pii: 5676855. doi: 10.1093.
    >> Share

  179. HENSS L, Yue C, von Rhein C, Tschismarov R, et al
    Analysis of humoral immune responses in chikungunya virus (CHIKV) infected patients and individuals vaccinated with a candidate CHIKV vaccine.
    J Infect Dis. 2019 Dec 12. pii: 5673548. doi: 10.1093.
    >> Share

  180. WAGSTAFFE HR, Clutterbuck EA, Bockstal V, Stoop JN, et al
    Antibody-Dependent Natural Killer Cell Activation after Ebola Vaccination.
    J Infect Dis. 2019 Dec 10. pii: 5672569. doi: 10.1093.
    >> Share

  181. ENDY TP, Keiser PB, Wang D, Jarman RG, et al
    Serologic Response of Two versus Three doses, Intradermal versus Intramuscular Administration of a Licensed Rabies Vaccine for Pre-Exposure Prophylaxis.
    J Infect Dis. 2019 Dec 5. pii: 5658469. doi: 10.1093.
    >> Share

    November 2019
  182. MARKOWITZ LE, Naleway AL, Klein NP, Lewis RM, et al
    Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses.
    J Infect Dis. 2019 Nov 30. pii: 5648192. doi: 10.1093.
    >> Share

  183. BONIFACE K, Byars SG, Cowley D, Kirkwood CD, et al
    Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.
    J Infect Dis. 2019 Nov 25. pii: 5640309. doi: 10.1093.
    >> Share

  184. TENG MN, Mejias A, Ramilo O, Peeples ME, et al
    Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
    J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
    >> Share

  185. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.
    J Infect Dis. 2019 Nov 23. pii: 5638036. doi: 10.1093.
    >> Share

  186. GLASS A, Polhemus M, Wang D, Jarman RG, et al
    The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine (CYD-TDV): A Phase II, Randomized, Open-label, Single Center Trial in Adults Aged 18 t
    J Infect Dis. 2019 Nov 22. pii: 5637716. doi: 10.1093.
    >> Share

  187. LO MK, Spengler JR, Welch SR, Harmon JR, et al
    Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
    J Infect Dis. 2019 Nov 21. pii: 5637464. doi: 10.1093.
    >> Share

  188. BEALL B, Van Beneden C
    Challenges to vaccine development-the diversity of group A streptococcal strains among varied climates and global regions.
    J Infect Dis. 2019 Nov 21. pii: 5636891. doi: 10.1093.
    >> Share

  189. KEITEL WA, Atmar RL
    Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
    J Infect Dis. 2019 Nov 20. pii: 5634378. doi: 10.1093.
    >> Share

  190. PUKSURIWONG S, Ahmed MS, Sharma R, Krishnan M, et al
    MVA-NP+M1 vaccine activates mucosal M1-specific T cell immunity and tissue-resident memory T cells in human nasopharynx-associated lymphoid tissue.
    J Infect Dis. 2019 Nov 19. pii: 5628940. doi: 10.1093.
    >> Share

  191. UGARTE A, Romero Y, Tricas A, Casado C, et al
    Unintended HIV-1 Infection During Analytical Therapy Interruption.
    J Infect Dis. 2019 Nov 19. pii: 5631859. doi: 10.1093.
    >> Share

  192. SMITH C, Moraka NO, Ibrahim M, Moyo S, et al
    HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.
    J Infect Dis. 2019 Nov 10. pii: 5618838. doi: 10.1093.
    >> Share

  193. WALKER JL, Zhao H, Dabrera G, Andrews N, et al
    Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015.
    J Infect Dis. 2019 Nov 9. pii: 5618766. doi: 10.1093.
    >> Share

  194. ENDY TP, Keiser PB, Cibula D, Abbott M, et al
    Effect of Antimalarial Drugs on the Immune Response to Intramuscular Rabies Vaccination Using a Postexposure Prophylaxis Regimen.
    J Infect Dis. 2019 Nov 2. pii: 5611063. doi: 10.1093.
    >> Share

  195. PLOTKIN SA
    Is There a Correlate of Protection for Measles Vaccine?
    J Infect Dis. 2019 Nov 1. pii: 5610905. doi: 10.1093.
    >> Share

    October 2019
  196. PATEL JC, Soeters HM, Diallo AO, Bicaba BW, et al
    MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa.
    J Infect Dis. 2019;220.
    >> Share

  197. NOVAK RT, Ronveaux O, Bita AF, Ake HF, et al
    Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.
    J Infect Dis. 2019;220.
    >> Share

  198. FERNANDEZ K, Lingani C, Aderinola OM, Goumbi K, et al
    Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
    J Infect Dis. 2019;220.
    >> Share

  199. BWAKA A, Bita A, Lingani C, Fernandez K, et al
    Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018.
    J Infect Dis. 2019;220.
    >> Share

  200. ALDERSON MR, LaForce FM, Sobanjo-Ter Meulen A, Hwang A, et al
    Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
    J Infect Dis. 2019;220.
    >> Share

  201. SOETERS HM, Kambire D, Sawadogo G, Ouedraogo-Traore R, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.
    J Infect Dis. 2019;220.
    >> Share

  202. ZOMA RL, Walldorf JA, Tarbangdo F, Patel JC, et al
    Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso.
    J Infect Dis. 2019;220.
    >> Share

  203. SIDIKOU F, Potts CC, Zaneidou M, Mbaeyi S, et al
    Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.
    J Infect Dis. 2019;220.
    >> Share

  204. COHEN C, Nunes MC
    Vaccinating Mothers to Protect Their Babies Against Influenza.
    J Infect Dis. 2019 Oct 31. pii: 5610713. doi: 10.1093.
    >> Share

  205. COOPER LV, Ronveaux O, Fernandez K, Lingani C, et al
    Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.
    J Infect Dis. 2019;220.
    >> Share

  206. NOVAK RT, Moisi JC, Tall H, Preziosi MP, et al
    Country Data for Action: The MenAfriNet Experience in Strengthening Meningitis Surveillance in Africa.
    J Infect Dis. 2019;220.
    >> Share

  207. MOUNKORO D, Nikiema CS, Maman I, Sakande S, et al
    Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.
    J Infect Dis. 2019;220.
    >> Share

  208. FLANNERY B, Kondor RJG, Chung JR, Gaglani M, et al
    Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season.
    J Infect Dis. 2019 Oct 30. pii: 5609441. doi: 10.1093.
    >> Share

  209. ATMAR RL, Keitel WA
    Searching for Improved Flu Vaccines - The Time Is Now.
    J Infect Dis. 2019 Oct 30. pii: 5609442. doi: 10.1093.
    >> Share

  210. CARBONI F, Angiolini F, Fabbrini M, Brogioni B, et al
    GBS type III oligosaccharides containing a minimal protective epitope can be turned into effective vaccines by multivalent presentation.
    J Infect Dis. 2019 Oct 23. pii: 5602691. doi: 10.1093.
    >> Share

  211. COELHO-DOS-REIS JGA, Funakoshi R, Huang J, Pereira FV, et al
    Functional Human CD141+ Dendritic Cells in Human Immune System Mice.
    J Infect Dis. 2019 Oct 23. pii: 5606696. doi: 10.1093.
    >> Share

  212. MATEO R, Lindesmith LC, Garg SJ, Gottlieb K, et al
    Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development.
    J Infect Dis. 2019 Oct 20. pii: 5601165. doi: 10.1093.
    >> Share

  213. BARTLETT S, Eichenberger RM, Nevagi RJ, Ghaffar KA, et al
    Lipopeptide-based oral vaccine against hookworm infection.
    J Infect Dis. 2019 Oct 17. pii: 5588831. doi: 10.1093.
    >> Share

  214. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged >/=65 Years.
    J Infect Dis. 2019 Oct 17. pii: 5588808. doi: 10.1093.
    >> Share

  215. KILAPANDAL VENKATRAMAN SM, Sivanandham R, Pandrea I, Apetrei C, et al
    BCG Vaccination and Mother-to-Infant Transmission of HIV.
    J Infect Dis. 2019 Oct 12. pii: 5586559. doi: 10.1093.
    >> Share

  216. WOOD MP, Wood LF, Templeton M, Fisher B, et al
    Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.
    J Infect Dis. 2019 Oct 12. pii: 5586557. doi: 10.1093.
    >> Share

  217. KARRON RA, Luongo C, Mateo JS, Wanionek K, et al
    Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/DeltaNS2/Delta1313/I1314L in RSV-Seronegative Children.
    J Infect Dis. 2019 Oct 12. pii: 5586371. doi: 10.1093.
    >> Share

  218. FRIES L, Cho I, Krahling V, Fehling SK, et al
    A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M Adjuvant in Healthy Adults.
    J Infect Dis. 2019 Oct 11. pii: 5585635. doi: 10.1093.
    >> Share

  219. BAUSCH DG, Piot P
    Ebola Vaccines: Biomedical Advances, Human Rights Challenges.
    J Infect Dis. 2019 Oct 11. pii: 5585661. doi: 10.1093.
    >> Share

  220. KARUNAKARAN KP, Yu H, Jiang X, Chan QWT, et al
    Discordance in the epithelial cell-dendritic cell MHC class II immunoproteome: implications for Chlamydia vaccine development.
    J Infect Dis. 2019 Oct 10. pii: 5585005. doi: 10.1093.
    >> Share

  221. KAO CM, Goymer J, Loh LN, Mahant A, et al
    Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies that Mediate Antibody Dependent Cellular Cytotoxicity in Protecting Neonates from Herpes Simplex Virus Type 1 and Type 2.
    J Infect Dis. 2019 Oct 10. pii: 5585046. doi: 10.1093.
    >> Share

  222. ROSS S, Pati P, Jensen TL, Goll JB, et al
    Cytomegalovirus genetic diversity following primary infection.
    J Infect Dis. 2019 Oct 8. pii: 5583881. doi: 10.1093.
    >> Share

  223. ELLSWORTH GB, Wilkin TJ
    Another Call for Widespread Human Papillomavirus Vaccination.
    J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
    >> Share

  224. BIANCHI FP, Stefanizzi P, De Nitto S, Larocca AMV, et al
    Long-term immunogenicity of Measles vaccine: an Italian retrospective cohort study.
    J Infect Dis. 2019 Oct 3. pii: 5580522. doi: 10.1093.
    >> Share

    September 2019
  225. COLEMAN KK, Wong CC, Jayakumar J, Nguyen TT, et al
    Adenoviral Infections in Singapore: Should New Antiviral Therapies and Vaccines Be Adopted?
    J Infect Dis. 2019 Sep 30. pii: 5576003. doi: 10.1093.
    >> Share


  226. Corrigendum to: Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015-2016.
    J Infect Dis. 2019 Sep 26. pii: 5574032. doi: 10.1093.
    >> Share

  227. L'HUILLIER AG, Ferreira VH, Hirzel C, Natori Y, et al
    Cell-Mediated Immune Responses after Influenza Vaccination of Solid Organ Transplant Recipients: a Secondary Outcomes Analysis of a Randomized Controlled Trial.
    J Infect Dis. 2019 Sep 24. pii: 5573328. doi: 10.1093.
    >> Share

  228. GERSHON AS, Chung H, Porter J, Campitelli MA, et al
    Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
    J Infect Dis. 2019 Sep 24. pii: 5573043. doi: 10.1093.
    >> Share

  229. RAMILO O, Rodriguez-Fernandez R, Peeples ME, Mejias A, et al
    Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.
    J Infect Dis. 2019 Sep 24. pii: 5573046. doi: 10.1093.
    >> Share

  230. KAREKO BW, Booty BL, Nix CD, Lyski ZL, et al
    Persistence of Neutralizing Antibody Responses Among Yellow Fever Virus 17D Vaccinees Living in a Nonendemic Setting.
    J Infect Dis. 2019 Sep 23. pii: 5572834. doi: 10.1093.
    >> Share

  231. BARRETT ADT
    Yellow Fever Vaccine: The Conundrum of 2 Doses, One Dose, or One-Fifth Dose to Induce and Maintain Protective Immunity.
    J Infect Dis. 2019 Sep 23. pii: 5572851. doi: 10.1093.
    >> Share

  232. PATEL P, Bush T, Conley L, Unger ER, et al
    Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.
    J Infect Dis. 2019 Sep 19. pii: 5571724. doi: 10.1093.
    >> Share

  233. NAHM MH, Brissac T, Kilian M, Vlach J, et al
    Pneumococci Can Become Virulent by Acquiring a New Capsule From Oral Streptococci.
    J Infect Dis. 2019 Sep 7. pii: 5564845. doi: 10.1093.
    >> Share

    August 2019
  234. HALPERIN SA, Das R, Onorato MT, Liu K, et al
    Immunogenicity, Lot Consistency, and Extended Safety of rVSVDeltaG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults.
    J Infect Dis. 2019;220:1127-1135.
    >> Share

  235. JOHNSON T, Folayan MO
    Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.
    J Infect Dis. 2019;220:1233-1234.
    >> Share

  236. KATELARIS AL, Jackson C, Southern J, Gupta RK, et al
    Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort.
    J Infect Dis. 2019 Aug 29. pii: 5556484. doi: 10.1093.
    >> Share

  237. TIFREA DF, Pal S, de la Maza LM
    A recombinant Chlamydia trachomatis MOMP vaccine elicits cross-serogroup protection in mice against vaginal shedding and infertility.
    J Infect Dis. 2019 Aug 28. pii: 5555888. doi: 10.1093.
    >> Share

  238. STACEY HD, Miller MS
    Repeated Seasonal Influenza Vaccination-How Much is Too Much of a Good Thing?
    J Infect Dis. 2019 Aug 26. pii: 5554481. doi: 10.1093.
    >> Share

  239. RICHARDS KA, Shannon I, Treanor JJ, Yang H, et al
    Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.
    J Infect Dis. 2019 Aug 26. pii: 5554480. doi: 10.1093.
    >> Share

  240. RACEY CS, Albert A, Donken R, Smith L, et al
    Cervical intraepithelial neoplasia rates in British Columbia women: A population level data linkage evaluation of the school-based HPV immunization program.
    J Infect Dis. 2019 Aug 23. pii: 5553681. doi: 10.1093.
    >> Share

  241. SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
    Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
    J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
    >> Share

  242. GODI A, Kemp TJ, Pinto LA, Beddows S, et al
    Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies.
    J Infect Dis. 2019 Aug 15. pii: 5550116. doi: 10.1093.
    >> Share

  243. SALPINI R, Pietrobattista A, Piermatteo L, Basso MS, et al
    Establishment of a seronegative occult infection with an active HBV reservoir enriched of vaccine escape mutations in a vaccinated infant after liver transplant.
    J Infect Dis. 2019 Aug 14. pii: 5550108. doi: 10.1093.
    >> Share

  244. CHOI YH, Perez-Cuevas MB, Kodani M, Zhang X, et al
    Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.
    J Infect Dis. 2019 Aug 13. pii: 5549399. doi: 10.1093.
    >> Share

  245. MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
    Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
    J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
    >> Share

  246. KURUP D, Fisher CR, Smith TG, Abreu-Mota T, et al
    Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge.
    J Infect Dis. 2019 Aug 3. pii: 5543203. doi: 10.1093.
    >> Share

    July 2019
  247. BOPPANA S, Sterrett S, Files J, Qin K, et al
    HLA-I associated adaptation dampens the CD8 T-cell response in HIV Ad5-vectored vaccine recipients.
    J Infect Dis. 2019 Jul 12. pii: 5532017. doi: 10.1093.
    >> Share

  248. LALVANI A, Seshadri C
    Understanding How BCG Vaccine Protects Against Mycobacterium tuberculosis Infection: Lessons From Household Contact Studies.
    J Infect Dis. 2019 Jul 12. pii: 5531579. doi: 10.1093.
    >> Share

  249. VERRALL AJ, Alisjahbana B, Apriani L, Novianty N, et al
    Early Clearance of Mycobacterium tuberculosis: The INFECT Case Contact Cohort Study in Indonesia.
    J Infect Dis. 2019 Jul 12. pii: 5531576. doi: 10.1093.
    >> Share

  250. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Effect of age on relative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries ages 65 years and older.
    J Infect Dis. 2019 Jul 9. pii: 5530548. doi: 10.1093.
    >> Share

  251. CHUA H, Chiu SS, Chan ELY, Feng S, et al
    Effectiveness of partial and full influenza vaccination in children aged <9 years in Hong Kong, 2011-2019.
    J Infect Dis. 2019 Jul 9. pii: 5530568. doi: 10.1093.
    >> Share

  252. ROMERO-SAAVEDRA F, Laverde D, Kalfopoulou E, Martini C, et al
    Conjugation of different immunogenic enterococcal vaccine target antigens leads to extended strain coverage.
    J Infect Dis. 2019 Jul 9. pii: 5530372. doi: 10.1093.
    >> Share

  253. XING X, Bi S, Fan X, Jin M, et al
    Intranasal Immunization with Multi-virulence Factors Promotes Mucosal Clearance of Streptococcus suis across Serotypes and Protects against Meningitis in Mice.
    J Infect Dis. 2019 Jul 9. pii: 5530315. doi: 10.1093.
    >> Share

  254. NG TWY, Perera RAPM, Fang VJ, Yau EM, et al
    The effect of influenza vaccination history on changes in hemagglutination inhibition titers following receipt of the 2015/16 influenza vaccine in older adults in Hong Kong.
    J Infect Dis. 2019 Jul 6. pii: 5529474. doi: 10.1093.
    >> Share

  255. MUTSAERTS EAML, Nunes MC, Bhikha S, Ikulinda BT, et al
    Immunogenicity and safety of an early measles vaccination schedule at 6 and 12 months of age in HIV-unexposed and HIV-exposed uninfected South African children.
    J Infect Dis. 2019 Jul 6. pii: 5529477. doi: 10.1093.
    >> Share

  256. ADLER SP, Lewis N, Conlon A, Christiansen MP, et al
    Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.
    J Infect Dis. 2019;220:411-419.
    >> Share

  257. SAVARINO SJ, McKenzie R, Tribble DR, Porter CK, et al
    Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model.
    J Infect Dis. 2019;220:505-513.
    >> Share

  258. JAGGER BW, Dowd KA, Chen RE, Desai P, et al
    Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.
    J Infect Dis. 2019 Jul 1. pii: 5526737. doi: 10.1093.
    >> Share

    June 2019
  259. LARTEY S, Zhou F, Brokstad KA, Mohn KG, et al
    Live attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction.
    J Infect Dis. 2019 Jun 27. pii: 5524503. doi: 10.1093.
    >> Share

  260. RESIK S, Mach O, Tejeda A, Jeyaseelan V, et al
    Immunogenicity of intramuscular fractional dose of inactivated poliovirus vaccine.
    J Infect Dis. 2019 Jun 26. pii: 5523769. doi: 10.1093.
    >> Share

  261. BANDYOPADHYAY AS, Orenstein WA
    Evolution of Inactivated Poliovirus Vaccine Use for the Endgame and Beyond.
    J Infect Dis. 2019 Jun 26. pii: 5523740. doi: 10.1093.
    >> Share

  262. LEWNARD JA, Givon-Lavi N, Dagan R
    Interaction with nontypeable Haemophilus influenzae alters progression of Streptococcus pneumoniae serotypes from colonization to upper respiratory tract diseases in children in a site-specific manner.
    J Infect Dis. 2019 Jun 22. pii: 5522408. doi: 10.1093.
    >> Share

  263. AFKHAMI S, Lai R, D'Agostino MR, Vaseghi-Shanjani M, et al
    Single-dose mucosal immunotherapy with chimpanzee adenovirus-based vaccine accelerates TB disease control and limits its rebound following antibiotic cessation.
    J Infect Dis. 2019 Jun 13. pii: 5519039. doi: 10.1093.
    >> Share

  264. ZHONG W, Levine MZ
    Stockpiled avian influenza A(H7N9) vaccines induce robust, non-neutralizing functional antibodies against antigenically drifted 5th wave A(H7N9) viruses.
    J Infect Dis. 2019 Jun 5. pii: 5511958. doi: 10.1093.
    >> Share

  265. BOGAARDS JA, van der Weele P, Woestenberg PJ, van Benthem BHB, et al
    Bivalent HPV Vaccine Effectiveness Correlates with Phylogenetic Distance from Hpv Vaccine Types 16 And 18.
    J Infect Dis. 2019 Jun 4. pii: 5511346. doi: 10.1093.
    >> Share

  266. SHAH JA, Lindestam Arlehamn CS, Horne DJ, Sette A, et al
    Non-tuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.
    J Infect Dis. 2019 Jun 4. pii: 5511511. doi: 10.1093.
    >> Share

  267. OLBRICH A, Wardemann H, Bohm S, Rother K, et al
    Repertoire and neutralizing activity of antibodies against E2 peptide in patients with spontaneous resolution of hepatitis C.
    J Infect Dis. 2019 Jun 4. pii: 5511345. doi: 10.1093.
    >> Share

  268. REIF DM, Chanock SJ, Edwards KM, Crowe JE, et al
    Inappropriate Citation of Vaccine Article.
    J Infect Dis. 2019 Jun 3. pii: 5510417. doi: 10.1093.
    >> Share

    May 2019
  269. GREGIANINI TS, Varella IRS, Fisch P, Martins LG, et al
    Dual and Triple Infections With Influenza A and B Viruses: A Case-Control Study in Southern Brazil.
    J Infect Dis. 2019 May 29. pii: 5481580. doi: 10.1093.
    >> Share

  270. MARTINEZ-BAZ I, Navascues A, Casado I, Aguinaga A, et al
    Remaining effect of influenza vaccines received in prior seasons.
    J Infect Dis. 2019 May 20. pii: 5492310. doi: 10.1093.
    >> Share

  271. SACCOCCIO FM, Jenks JA, Itell HL, Li SH, et al
    Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.
    J Infect Dis. 2019 May 20. pii: 5492326. doi: 10.1093.
    >> Share

  272. ZAUBERMAN A, Gur D, Levy Y, Aftalion M, et al
    Post-exposure administration of a Yersinia pestis live vaccine potentiates second-line antibiotic treatment against pneumonic plague.
    J Infect Dis. 2019 May 16. pii: 5490663. doi: 10.1093.
    >> Share

  273. YAN Y, Wang X, Lou P, Hu Z, et al
    A nanoparticle-based HCV vaccine with enhanced potency.
    J Infect Dis. 2019 May 10. pii: 5487910. doi: 10.1093.
    >> Share

  274. LAIDLAW SM, Dustin LB
    An HCV vaccine on the fly.
    J Infect Dis. 2019 May 10. pii: 5487908. doi: 10.1093.
    >> Share

  275. DROPULIC LK, Oestreich MC, Pietz HL, Laing KJ, et al
    A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus 2 Vaccine, HSV529, in Adults With or Without HSV Infection.
    J Infect Dis. 2019 May 6. pii: 5486075. doi: 10.1093.
    >> Share

  276. MURRAY AF, Englund JA, Kuypers J, Tielsch JM, et al
    Infant pneumococcal carriage during influenza, RSV and hMPV respiratory illness within a maternal influenza immunization trial.
    J Infect Dis. 2019 May 6. pii: 5485855. doi: 10.1093.
    >> Share

  277. ROSSI SL, Comer JE, Wang E, Azar SR, et al
    Immunogenicity and Efficacy of a Measles Virus-vectored Chikungunya Vaccine in Nonhuman Primates.
    J Infect Dis. 2019 May 3. pii: 5485499. doi: 10.1093.
    >> Share

  278. AMOAH S, Mishina M, Praphasiri P, Cao W, et al
    Standard dose intradermal influenza vaccine elicits similar cellular immune responses when compared to intramuscular vaccine in HIV-infected or uninfected men.
    J Infect Dis. 2019 May 2. pii: 5482500. doi: 10.1093.
    >> Share

    April 2019
  279. WOESTENBERG PJ, King AJ, Van Benthem BHB, Leussink S, et al
    Bivalent Vaccine Effectiveness Against Anal Human Papillomavirus Positivity Among Female Sexually Transmitted Infection Clinic Visitors in the Netherlands.
    J Infect Dis. 2019 Apr 23. pii: 5476422. doi: 10.1093.
    >> Share

  280. PATRICIA K, Wijmenga-Monsuur AJ, van Houten MA, Veldhuijzen IK, et al
    A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults.
    J Infect Dis. 2019 Apr 23. pii: 5476427. doi: 10.1093.
    >> Share

  281. HAYDEN CA, Hung CY, Zhang H, Negron A, et al
    Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
    J Infect Dis. 2019 Apr 23. pii: 5479236. doi: 10.1093.
    >> Share

  282. KANDASAMY R, Voysey M, Collins S, Berbers G, et al
    Persistent circulation of vaccine serotypes and serotype replacement after five years of UK infant immunisation with PCV13.
    J Infect Dis. 2019 Apr 20. pii: 5475435. doi: 10.1093.
    >> Share

  283. PILISHVILI T
    Pneumococcal conjugate vaccine effects in the United Kingdom: success of vaccine policy and remaining opportunities for prevention.
    J Infect Dis. 2019 Apr 20. pii: 5475438. doi: 10.1093.
    >> Share

  284. LEE AD, Clemmons NS, Patel M, Gastanaduy PA, et al
    International Importations of Measles Virus into the United States During the Postelimination Era, 2001-2016.
    J Infect Dis. 2019;219:1616-1623.
    >> Share

  285. ATMAR RL, Baehner F, Cramer JP, Lloyd E, et al
    Antibody persistence to two Virus-Like Particle norovirus vaccine candidate formulations in healthy adults: one-year follow-up with memory probe vaccination.
    J Infect Dis. 2019 Apr 18. pii: 5475178. doi: 10.1093.
    >> Share

  286. BRINKMAN ID, de Wit J, Smits GP, Ten Hulscher HI, et al
    Early measles vaccination during an outbreak in The Netherlands: reduced short and long-term antibody responses in children vaccinated before 12 months of age.
    J Infect Dis. 2019 Apr 11. pii: 5441452. doi: 10.1093.
    >> Share

  287. SUTTER RW, Cochi SL
    Inactivated Poliovirus Vaccine Supply Shortage: Is There Light at the End of the Tunnel?
    J Infect Dis. 2019 Apr 8. pii: 5432103. doi: 10.1093.
    >> Share

  288. HU Y, Wang J, Zeng G, Chu K, et al
    Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial.
    J Infect Dis. 2019 Apr 8. pii: 5431722. doi: 10.1093.
    >> Share

  289. MEILLEUR CE, Wardell CM, Mele TS, Dikeakos JD, et al
    Bacterial Superantigens Expand and Activate, Rather than Delete or Incapacitate, Preexisting Antigen-Specific Memory CD8+ T Cells.
    J Infect Dis. 2019;219:1307-1317.
    >> Share

  290. CHEN C, van Schaik EJ, Gregory AE, Vigil A, et al
    Chemokine Receptor 7 is Essential for Coxiella burnetii Whole-Cell Vaccine Induced Cellular Immunity but Dispensable for Vaccine Mediated Protective Immunity.
    J Infect Dis. 2019 Apr 2. pii: 5425888. doi: 10.1093.
    >> Share

    March 2019
  291. HASHEM AM, Algaissi A, Agrawal A, Al-Amri SS, et al
    A highly immunogenic, protective and safe adenovirus-based vaccine expressing MERS-CoV S1-CD40L fusion protein in transgenic human DPP4 mouse model.
    J Infect Dis. 2019 Mar 26. pii: 5419855. doi: 10.1093.
    >> Share

  292. SWANSTROM JA, Nivarthi UK, Patel B, Delacruz MJ, et al
    Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by NIH Monovalent Dengue Virus Vaccines.
    J Infect Dis. 2019 Mar 21. pii: 5416140. doi: 10.1093.
    >> Share

  293. TEBAS P, Kraynyak KA, Patel A, Maslow JN, et al
    Intradermal SynCon(R) Ebola GP DNA Vaccine is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers.
    J Infect Dis. 2019 Mar 19. pii: 5395966. doi: 10.1093.
    >> Share

  294. ZHANG Z, Liang Z, Zeng J, Zhang J, et al
    Immunogenicity and safety of an inactivated enterovirus 71 vaccine administered simultaneously with recombinant hepatitis B vaccine and group A meningococcal polysaccharide vaccine: a phase IV, open-label, single-center, randomized, non-inferiority tr
    J Infect Dis. 2019 Mar 19. pii: 5395971. doi: 10.1093.
    >> Share

  295. WANG Y, Esquivel R, Flingai S, Schiller ZA, et al
    Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice.
    J Infect Dis. 2019;219:1146-1150.
    >> Share

  296. DEY RJ, Dey B, Singh AK, Praharaj M, et al
    BCG overexpressing an endogenous STING agonist provides enhanced protection against pulmonary tuberculosis.
    J Infect Dis. 2019 Mar 15. pii: 5381716. doi: 10.1093.
    >> Share

  297. HUYEN DTT, Mach O, Trung NT, Thai PQ, et al
    Rapid Disappearance of Poliovirus Type 2 Immunity in Young Children Following Withdrawal of Oral Poliovirus Type 2 Containing Vaccine in Vietnam.
    J Infect Dis. 2019 Mar 14. pii: 5380634. doi: 10.1093.
    >> Share

    February 2019
  298. ITURRIZA-GOMARA M, Jere KC, Hungerford D, Bar-Zeev N, et al
    Aetiology of diarrhoea among hospitalised children in Blantyre, Malawi following rotavirus vaccine introduction: a case-control study.
    J Infect Dis. 2019 Feb 28. pii: 5366554. doi: 10.1093.
    >> Share

  299. BARANIAK I, Kern F, Holenya P, Griffiths P, et al
    Original antigenic sin shapes the immunological repertoire evoked by HCMV gB-MF59 vaccine in seropositive recipients.
    J Infect Dis. 2019 Feb 27. pii: 5366424. doi: 10.1093.
    >> Share

  300. ANYWAINE Z, Whitworth H, Kaleebu P, Praygod G, et al
    Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania.
    J Infect Dis. 2019 Feb 23. pii: 5364034. doi: 10.1093.
    >> Share

  301. MUTUA G, Anzala O, Luhn K, Robinson C, et al
    Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Nairobi, Kenya.
    J Infect Dis. 2019 Feb 23. pii: 5364047. doi: 10.1093.
    >> Share

  302. CRAWT L, Atkinson E, Tedcastle A, Pegg E, et al
    Differences in antigenic structure of inactivated poliovaccines made from Sabin live-attenuated and wild-type poliovirus strains: impact on vaccine potency assays.
    J Infect Dis. 2019 Feb 21. pii: 5351027. doi: 10.1093.
    >> Share

  303. MODLIN J, Chumakov K
    Sabin Strain Inactivated Polio Vaccine for the Polio Endgame.
    J Infect Dis. 2019 Feb 21. pii: 5351111. doi: 10.1093.
    >> Share

  304. SHARMA M, Glasner DR, Watkins H, Puerta-Guardo H, et al
    Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate.
    J Infect Dis. 2019 Feb 19. pii: 5345046. doi: 10.1093.
    >> Share

  305. BUURMAN ET, Timofeyeva Y, Gu J, Kim JH, et al
    A novel hexavalent capsular polysaccharide conjugate vaccine (GBS6) for the prevention of neonatal group B streptococcal infections by maternal immunization.
    J Infect Dis. 2019 Feb 19. pii: 5336091. doi: 10.1093.
    >> Share

  306. LELIEVRE JD, Hocqueloux L
    Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.
    J Infect Dis. 2019 Feb 16. pii: 5344456. doi: 10.1093.
    >> Share

  307. GRAY GC
    Adenovirus 4 and 7 vaccine: New Body Armor for Marine Officer Trainees.
    J Infect Dis. 2019 Feb 6. pii: 5308337. doi: 10.1093.
    >> Share

  308. ZELNER J, Petrie JG, Trangucci R, Martin ET, et al
    Effects of sequential influenza A(H1N1)pdm09 vaccination on antibody waning.
    J Infect Dis. 2019 Feb 4. pii: 5306487. doi: 10.1093.
    >> Share

  309. LEVINE MZ, Martin ET, Petrie JG, Lauring AS, et al
    Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season.
    J Infect Dis. 2019 Feb 4. pii: 5306481. doi: 10.1093.
    >> Share

  310. FOLSCHWEILLER N, Behre U, Dionne M, Durando P, et al
    Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
    J Infect Dis. 2019 Feb 3. pii: 5306135. doi: 10.1093.
    >> Share

    January 2019
  311. PAULES CI, Fauci AS
    Influenza Vaccines: Good, But We Can Do Better.
    J Infect Dis. 2019 Jan 31. pii: 5304932. doi: 10.1093.
    >> Share

  312. SAAD-ROY CM, McDermott AB, Grenfell BT
    Dynamic perspectives on the search for a universal influenza vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304934. doi: 10.1093.
    >> Share

  313. CRANK MC, Mascola JR, Graham BS
    Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304928. doi: 10.1093.
    >> Share

  314. RUDRARAJU R, Mordant F, Subbarao K
    How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304927. doi: 10.1093.
    >> Share

  315. ROSS TM
    Universal Influenza Vaccine Approaches Employing Full-Length or Head-only HA Proteins.
    J Infect Dis. 2019 Jan 31. pii: 5304925. doi: 10.1093.
    >> Share

  316. SAELENS X
    The Role of M2e in the Development of Universal Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304896. doi: 10.1093.
    >> Share

  317. KANEKIYO M, Ellis D, King NP
    New Vaccine Design and Delivery Technologies.
    J Infect Dis. 2019 Jan 31. pii: 5304933. doi: 10.1093.
    >> Share

  318. EICHELBERGER MC, Monto AS
    Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection.
    J Infect Dis. 2019 Jan 31. pii: 5304892. doi: 10.1093.
    >> Share

  319. KRAMMER F, Palese P
    Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain.
    J Infect Dis. 2019 Jan 31. pii: 5304926. doi: 10.1093.
    >> Share

  320. MORENS DM, Taubenberger JK
    Making Universal Influenza Vaccines: Lessons from the 1918 Pandemic.
    J Infect Dis. 2019 Jan 31. pii: 5304851. doi: 10.1093.
    >> Share

  321. ORTIZ JR, Neuzil KM
    Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304930. doi: 10.1093.
    >> Share

  322. SANT AJ
    The way forward: Potentiating protective immunity to novel and pandemic influenza through engagement of memory CD4 T cells.
    J Infect Dis. 2019 Jan 31. pii: 5304931. doi: 10.1093.
    >> Share

  323. CROWE JE JR
    Antibody Determinants of Influenza Immunity.
    J Infect Dis. 2019 Jan 31. pii: 5304924. doi: 10.1093.
    >> Share

  324. ADLER H, Nikolaou E, Gould K, Hinds J, et al
    Pneumococcal colonization in healthy adult research participants in the conjugate vaccine era, United Kingdom, 2010-2017.
    J Infect Dis. 2019 Jan 28. pii: 5303784. doi: 10.1093.
    >> Share

  325. BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
    Infrequent Transmission of Monovalent Human Rotavirus Vaccine Virus to Household Contacts of Vaccinated Infants in Malawi.
    J Infect Dis. 2019 Jan 24. pii: 5300242. doi: 10.1093.
    >> Share

  326. GILKEY MB, Margolis MA
    Human Papillomavirus Vaccination Coverage Gaps in Young Adolescents.
    J Infect Dis. 2019 Jan 17. pii: 5265336. doi: 10.1093.
    >> Share

  327. BEDNARCZYK RA, Ellingson MK, Omer SB
    Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.
    J Infect Dis. 2019 Jan 17. pii: 5265326. doi: 10.1093.
    >> Share

  328. GAMAGE D, Mach O, Ginige S, Weldon WC, et al
    Poliovirus type 2 seroprevalence following full or fractional-dose of inactivated poliovirus vaccine in the period after Sabin type 2 withdrawal in Sri Lanka.
    J Infect Dis. 2019 Jan 11. pii: 5288498. doi: 10.1093.
    >> Share

  329. NEALON J, Taurel AF, Yoksan S, Moureau A, et al
    Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries.
    J Infect Dis. 2019;219:375-381.
    >> Share

  330. PHIPPS JP, Haas KM
    An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.
    J Infect Dis. 2019;219:323-334.
    >> Share

  331. MAZUR NI, Horsley NM, Englund JA, Nederend M, et al
    Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
    J Infect Dis. 2019;219:59-67.
    >> Share

    December 2018
  332. SU WJ, Chen SF, Yang CH, Chuang PH, et al
    The Impact of Universal Infant Hepatitis B Immunization on reducing the Hepatitis B Carrier Rate in Pregnant Women.
    J Infect Dis. 2018 Dec 20. pii: 5253892. doi: 10.1093.
    >> Share

  333. HOWARD LM, Goll JB, Jensen TL, Hoek KL, et al
    AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures In Human Peripheral Blood Mononuclear Cells.
    J Infect Dis. 2018 Dec 19. pii: 5253567. doi: 10.1093.
    >> Share

  334. YANG YYM, Wilson RA, Thomas SRL, Kariuki TM, et al
    Micro array-assisted analysis of anti-schistosome glycan antibodies elicited by protective vaccination with irradiated cercariae.
    J Infect Dis. 2018 Dec 18. pii: 5250920. doi: 10.1093.
    >> Share

  335. FLANNERY B, Fry AM
    Comparing influenza vaccine types: the path towards improved influenza vaccine strategies.
    J Infect Dis. 2018 Dec 18. pii: 5250956. doi: 10.1093.
    >> Share

  336. IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
    Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017-18.
    J Infect Dis. 2018 Dec 18. pii: 5250955. doi: 10.1093.
    >> Share

  337. BOLAY FK, Grandits G, Lane HC, Kennedy SB, et al
    PREVAIL I cluster vaccination study with rVSVG-ZEBOV-GP as part of a public health response in Liberia.
    J Infect Dis. 2018 Dec 17. pii: 5250908. doi: 10.1093.
    >> Share

  338. NG TWY, Cowling BJ, Gao HZ, Thompson MG, et al
    Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis.
    J Infect Dis. 2018 Dec 14. pii: 5247419. doi: 10.1093.
    >> Share

  339. KEITEL WA, Atmar RL
    Influenza Vaccines after Seven Decades: Still on the Learning Curve.
    J Infect Dis. 2018 Dec 14. pii: 5248489. doi: 10.1093.
    >> Share

  340. FERDINANDS JM, Gaglani M, Martin ET, Middleton D, et al
    Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    J Infect Dis. 2018 Dec 14. pii: 5248488. doi: 10.1093.
    >> Share

  341. BARTSCH SM, Asti L, Cox S, Durham DP, et al
    What is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks.
    J Infect Dis. 2018 Dec 13. pii: 5244597. doi: 10.1093.
    >> Share

  342. KAWAI K, Yawn BP
    Risk of Herpes Zoster in Cancer Patients and the Promise of New Vaccines.
    J Infect Dis. 2018 Dec 13. pii: 5234725. doi: 10.1093.
    >> Share

  343. ZOST SJ, Wu NC, Hensley SE, Wilson IA, et al
    Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens.
    J Infect Dis. 2018 Dec 9. pii: 5236836. doi: 10.1093.
    >> Share

    November 2018
  344. SANYAL M, Holmes TH, Maecker H, Albrecht RA, et al
    Diminished B-cell response after repeat influenza vaccination.
    J Infect Dis. 2018 Nov 28. pii: 5212478. doi: 10.1093.
    >> Share

  345. POETSCH JH, Dahlke C, Zinser ME, Kasonta R, et al
    Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans.
    J Infect Dis. 2018 Nov 17. pii: 5187947. doi: 10.1093.
    >> Share

  346. FINN A
    The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
    J Infect Dis. 2018 Nov 16. pii: 5184715. doi: 10.1093.
    >> Share

  347. GERSHON AA, Brooks D, Stevenson DD, Chin WK, et al
    High Constitutive IL-10 Interferes with the Immune Response to Varicella-Zoster Virus (VZV) in Elderly Recipients of Live Attenuated Zoster Vaccine.
    J Infect Dis. 2018 Nov 16. pii: 5184646. doi: 10.1093.
    >> Share

  348. VENKATRAMAN N, Ndiaye BP, Bowyer G, Wade D, et al
    Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen - ChAd3-EBO-Z followed by MVA-EBO-Z in healthy adults in the UK and Senegal.
    J Infect Dis. 2018 Nov 8. pii: 5164386. doi: 10.1093.
    >> Share

    October 2018
  349. ROSENBERG T, Philipsen BB, Mehlum CS, Dyrvig AK, et al
    Therapeutic use of the HPV vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis.
    J Infect Dis. 2018 Oct 25. pii: 5144565. doi: 10.1093.
    >> Share

  350. ARMAH GE, Cortese MM, Dennis FE, Yu Y, et al
    Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
    J Infect Dis. 2018 Oct 24. pii: 5144065. doi: 10.1093.
    >> Share

  351. BEERNINK PT, Ispasanie E, Lewis LA, Ram S, et al
    A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed Factor H binding protein elicits gonococcal bactericidal antibodies.
    J Infect Dis. 2018 Oct 20. pii: 5139647. doi: 10.1093.
    >> Share

  352. PATEL A, Reuschel EL, Kraynyak KA, Racine T, et al
    Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines.
    J Infect Dis. 2018 Oct 10. pii: 5123708. doi: 10.1093.
    >> Share

  353. KUDO R, Yamaguchi M, Sekine M, Adachi S, et al
    Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection.
    J Infect Dis. 2018 Oct 9. pii: 5115492. doi: 10.1093.
    >> Share

    September 2018
  354. PRAHARAJ I, Parker EPK, Giri S, Allen DJ, et al
    Influence of non-polio enteroviruses and the bacterial gut microbiota on oral poliovirus vaccine response: a study from south India.
    J Infect Dis. 2018 Sep 24. pii: 5106276. doi: 10.1093.
    >> Share

  355. RAMANI S, Harris V
    Going Viral! Unraveling the Impact of Non-polio Enteroviruses on Oral Vaccine Responses.
    J Infect Dis. 2018 Sep 24. pii: 5106282. doi: 10.1093.
    >> Share

  356. PATEL NP, Vukmanovic-Stejic M, Suarez-Farinas M, Chambers ES, et al
    Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge.
    J Infect Dis. 2018;218.
    >> Share

  357. HARPAZ R, van Hoek AJ
    Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
    J Infect Dis. 2018;218.
    >> Share

  358. GILBERT PB, Luedtke AR
    Statistical Learning Methods to Determine Immune Correlates of Herpes Zoster in Vaccine Efficacy Trials.
    J Infect Dis. 2018;218.
    >> Share

  359. WEINBERG A, Kroehl ME, Johnson MJ, Hammes A, et al
    Comparative Immune Responses to Licensed Herpes Zoster Vaccines.
    J Infect Dis. 2018;218.
    >> Share

  360. TSENG HF, Sy LS
    Use of Real-world Evidence to Evaluate the Effectiveness of Herpes Zoster Vaccine.
    J Infect Dis. 2018;218.
    >> Share

  361. CUNNINGHAM AL, Levin MJ
    Herpes Zoster Vaccines.
    J Infect Dis. 2018;218.
    >> Share

  362. BREUER J
    Molecular Genetic Insights Into Varicella Zoster Virus (VZV), the vOka Vaccine Strain, and the Pathogenesis of Latency and Reactivation.
    J Infect Dis. 2018;218.
    >> Share

  363. PARKER EPK, Whitfield H, Baskar C, Giri S, et al
    FUT2 secretor status is not associated with oral poliovirus vaccine immunogenicity in south Indian infants.
    J Infect Dis. 2018 Sep 19. pii: 5102389. doi: 10.1093.
    >> Share

  364. ARTEMCHUK H, Eriksson T, Poljak M, Surcel HM, et al
    Long-Term Antibody Response to Human Papillomavirus Vaccines: up to 12 Years Follow-Up in the Finnish Maternity Cohort.
    J Infect Dis. 2018 Sep 18. pii: 5099444. doi: 10.1093.
    >> Share

  365. SCHALTZ-BUCHHOLZER F, Biering-Sorensen S, Lund N, Monteiro I, et al
    Early Bacille Calmette-Guerin vaccination, hospitalizations and hospital deaths: Analysis of a secondary outcome in three randomized trials from Guinea-Bissau.
    J Infect Dis. 2018 Sep 18. pii: 5099442. doi: 10.1093.
    >> Share

  366. CIGLENECKI I, Azman AS, Jamet C, Serafini M, et al
    Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Medecins Sans Frontieres Experience.
    J Infect Dis. 2018 Sep 14. pii: 5098246. doi: 10.1093.
    >> Share

  367. ATMAR RL, Cramer JP, Baehner F, Han C, et al
    An exploratory study of the salivary IgA responses to one dose of a Norovirus VLP candidate vaccine in healthy adults.
    J Infect Dis. 2018 Sep 10. pii: 5094041. doi: 10.1093.
    >> Share

  368. MARSHALL HS, Clarke M, Heath C, Quinn H, et al
    Severe and complicated varicella and associated genotypes 10 years after introduction of a one dose varicella vaccine program.
    J Infect Dis. 2018 Sep 3. pii: 5089719. doi: 10.1093.
    >> Share

  369. HARRIS JB
    Cholera: Immunity and Prospects in Vaccine Development.
    J Infect Dis. 2018 Sep 1. pii: 5089248. doi: 10.1093.
    >> Share

    August 2018
  370. WEINBERG A, Popmihajlov Z, Schmader KE, Johnson MJ, et al
    Persistence of varicella-zoster virus cell-mediated immunity after the administration of a second dose of live herpes zoster vaccine.
    J Infect Dis. 2018 Aug 28. pii: 5084879. doi: 10.1093.
    >> Share

  371. SCHWETZ TA, Fauci AS
    The Extended Impact of Human Immunodeficiency Virus/AIDS Research.
    J Infect Dis. 2018 Aug 28. pii: 5063659. doi: 10.1093.
    >> Share

  372. LI Z, Chang P, Xu J, Tan C, et al
    A Streptococcus suis live vaccine suppresses streptococcal toxic shock-like syndrome and provides sequence type independent protectionTITLE.
    J Infect Dis. 2018 Aug 27. pii: 5081797. doi: 10.1093.
    >> Share

  373. CAGIGI A, Ploquin A, Niezold T, Zhou Y, et al
    Vaccine-Mediated Induction of an Ebolavirus Cross-Species Antibody Binding to Conserved Epitopes on the Glycoprotein Heptad Repeat 2/Membrane-Proximal External Junction.
    J Infect Dis. 2018 Aug 22. pii: 5078072. doi: 10.1093.
    >> Share

  374. CHANOUZAS D, Sagmeister M, Faustini S, Nightingale P, et al
    Subclinical reactivation of cytomegalovirus drives CD4+CD28null T-cell expansion and impaired immune response to pneumococcal vaccination in ANCA-associated vasculitis.
    J Infect Dis. 2018 Aug 9. pii: 5068409. doi: 10.1093.
    >> Share

  375. VELAZQUEZ-MOCTEZUMA R, Galli A, Law M, Bukh J, et al
    Hepatitis C virus escape studies for human monoclonal antibody AR4A reveal isolate-specific resistance and a high barrier to resistance.
    J Infect Dis. 2018 Aug 9. pii: 5068268. doi: 10.1093.
    >> Share

  376. WATANABE S, Tan NWW, Chan KWK, Vasudevan SG, et al
    Dengue and Zika Virus Serological Cross-reactivity and their Impact on Pathogenesis in Mice.
    J Infect Dis. 2018 Aug 2. pii: 5064258. doi: 10.1093.
    >> Share

  377. LIANG Y, Che Y, Yang B, Zhan F, et al
    Immunogenicity and safety of an F-genotype attenuated mumps vaccine in healthy 8- to 24-month-old children.
    J Infect Dis. 2018 Aug 1. pii: 5063175. doi: 10.1093.
    >> Share

  378. LAZCANO-PONCE E, Torres-Ibarra L, Cruz-Valdez A, Salmeron J, et al
    Persistence of immunity when using different HPV vaccination schedules and booster dose effects at 5 years post-primary vaccination.
    J Infect Dis. 2018 Aug 1. pii: 5063117. doi: 10.1093.
    >> Share

    July 2018
  379. SUSCHAK JJ, Bagley K, Shoemaker CJ, Six C, et al
    The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice.
    J Infect Dis. 2018 Jul 19. pii: 5056373. doi: 10.1093.
    >> Share

  380. HUANG QS, Bandaranayake D, Wood T, Newbern EC, et al
    Risk factors and attack rates of seasonal influenza infection: results of the SHIVERS seroepidemiologic cohort study.
    J Infect Dis. 2018 Jul 17. pii: 5054657. doi: 10.1093.
    >> Share

  381. FEIRING B, Laake I, Christiansen IK, Hansen M, et al
    Substantial decline in prevalence of vaccine-type and non-vaccine type HPV in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway.
    J Infect Dis. 2018 Jul 16. pii: 5054086. doi: 10.1093.
    >> Share

  382. POPPER SJ, Strouts FR, Lindow JC, Cheng HK, et al
    Early transcriptional responses after dengue vaccination mirror the response to natural infection and predict neutralizing antibody titers.
    J Infect Dis. 2018 Jul 14. pii: 5053882. doi: 10.1093.
    >> Share

  383. COWLING BJ, Sullivan SG
    The value of neuraminidase inhibition antibody titers in influenza seroepidemiology.
    J Infect Dis. 2018 Jul 14. pii: 5053899. doi: 10.1093.
    >> Share

  384. CAGIGI A, Misasi J, Ploquin A, Stanley DA, et al
    Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures.
    J Infect Dis. 2018 Jul 12. pii: 5052389. doi: 10.1093.
    >> Share

  385. VAN WAGONER N, Fife K, Leone PA, Bernstein DI, et al
    Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-controlled Trial.
    J Infect Dis. 2018 Jul 6. pii: 5049813. doi: 10.1093.
    >> Share

  386. ANGUIANO-ZARATE SS, Matchett WE, Nehete P, Sastry KJ, et al
    A Replicating Single-cycle Adenovirus Vaccine against Ebola Virus.
    J Infect Dis. 2018 Jul 6. pii: 5049708. doi: 10.1093.
    >> Share

  387. HOLBROOK MR
    Will a single-cycle Adenovirus vaccine be effective against Ebola virus?
    J Infect Dis. 2018 Jul 6. pii: 5049709. doi: 10.1093.
    >> Share

  388. YOUSAFZAI MT
    Role of fractional dose intradermal inactivated poliovirus vaccine in halting polio transmission: finding the missing piece for global polio eradication.
    J Infect Dis. 2018 Jul 5. pii: 5049362. doi: 10.1093.
    >> Share

  389. GAMAGE D, Mach O, Palihawadana P, Zhang Y, et al
    Boosting of mucosal immunity after fractional-dose inactivated poliovirus vaccine.
    J Infect Dis. 2018 Jul 5. pii: 5049361. doi: 10.1093.
    >> Share

    June 2018
  390. WARFIELD KL, Howell KA, Vu H, Geisbert J, et al
    Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms.
    J Infect Dis. 2018 Jun 25. pii: 5043486. doi: 10.1093.
    >> Share

  391. FUENTES S, Ravichandran S, Khurana S
    Antibody Repertoire of Human Polyclonal Antibodies Against Ebola Virus Glycoprotein Generated After Deoxyribonucleic Acid and Protein Vaccination of Transchromosomal Bovines.
    J Infect Dis. 2018 Jun 25. pii: 5043463. doi: 10.1093.
    >> Share

  392. LIU F, Tzeng WP, Horner L, Kamal RP, et al
    Both Immune Priming and Egg-adaptation in the Vaccine Influence Antibody Responses to Circulating A(H1N1)pdm09 Viruses Following Influenza Vaccination in Adults.
    J Infect Dis. 2018 Jun 21. pii: 5042019. doi: 10.1093.
    >> Share

  393. SOUCY AM, Hurteau GJ, Metzger DW
    Live vaccination generates both disease tolerance and host resistance during chronic pulmonary infection with highly virulent F. tularensis SchuS4.
    J Infect Dis. 2018 Jun 20. pii: 5040507. doi: 10.1093.
    >> Share

  394. MESHER D, Panwar K, Thomas SL, Edmundson C, et al
    The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.
    J Infect Dis. 2018 Jun 18. pii: 5025126. doi: 10.1093.
    >> Share

  395. LIU Y, Ye L, Lin F, Gomaa Y, et al
    Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.
    J Infect Dis. 2018 Jun 8. pii: 5034941. doi: 10.1093.
    >> Share

  396. ALI A, Ng HL, Blankson JN, Burton DR, et al
    Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1.
    J Infect Dis. 2018 Jun 7. pii: 5033983. doi: 10.1093.
    >> Share

    May 2018
  397. SWANSTROM JA, Henein S, Plante JA, Yount BL, et al
    Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate.
    J Infect Dis. 2018;217:1932-1941.
    >> Share

  398. KAINULAINEN MH, Spengler JR, Welch SR, Coleman-McCray JD, et al
    Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.
    J Infect Dis. 2018;217:1957-1966.
    >> Share

  399. PERCIANI CT, Sekhon M, Hundal S, Farah B, et al
    Live-attenuated Zoster Vaccine Boosts VZV-specific Humoral Responses Systemically and at the Cervico-vaginal Mucosa of Kenyan VZV-seropositive Women.
    J Infect Dis. 2018 May 25. pii: 5003463. doi: 10.1093.
    >> Share

  400. CHAKRABORTY S, Randall A, Vickers TJ, Molina D, et al
    Human experimental challenge with enterotoxigenic Escherichia coli elicits immune responses to canonical and novel antigens relevant to vaccine development.
    J Infect Dis. 2018 May 24. pii: 5003007. doi: 10.1093.
    >> Share

  401. PAMNANI SJ, Sudenga SL, Rollison DE, Ingles DJ, et al
    Recurrence of Genital Infections with Nine HPV Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) among Men in the HPV Infection in Men (HIM) Study.
    J Infect Dis. 2018 May 24. pii: 5002064. doi: 10.1093.
    >> Share

  402. BERNSTEIN DI
    Rotavirus Vaccines: Mind Your Ps and Gs.
    J Infect Dis. 2018 May 22. pii: 5001445. doi: 10.1093.
    >> Share

  403. ROCZO-FARKAS S, Kirkwood CD, Cowley D, Barnes GL, et al
    The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data.
    J Infect Dis. 2018 May 22. pii: 5001444. doi: 10.1093.
    >> Share

  404. KABINEH AK, Carr W, Motevalli M, Legardy-Williams J, et al
    Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience.
    J Infect Dis. 2018;217.
    >> Share

  405. CARTER RJ, Senesi RGB, Dawson P, Gassama I, et al
    Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2018;217.
    >> Share

  406. CONTEH MA, Goldstein ST, Wurie HR, Gidudu J, et al
    Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    J Infect Dis. 2018;217.
    >> Share

  407. JARRETT OD, Seward JF, Fombah AE, Lindblad R, et al
    Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    J Infect Dis. 2018;217.
    >> Share

  408. SAMAI M, Seward JF, Goldstein ST, Mahon BE, et al
    The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSVG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.
    J Infect Dis. 2018;217.
    >> Share

  409. SCHUCHAT A, Seward JF, Goldstein ST, Mahon BE, et al
    Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2018;217.
    >> Share

  410. CARTER RJ, Idriss A, Widdowson MA, Samai M, et al
    Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    J Infect Dis. 2018;217.
    >> Share

  411. FOMBAH AE, Goldstein ST, Jarrett OD, Jalloh MI, et al
    Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2018;217.
    >> Share

  412. EDEM-HOTAH J, McDonald W, Abu PM, Luman ET, et al
    Utilizing Nurses to Staff an Ebola Vaccine Clinical Trial in Sierra Leone during the Ebola Outbreak.
    J Infect Dis. 2018;217.
    >> Share

  413. JUSU MO, Glauser G, Seward JF, Bawoh M, et al
    Rapid Establishment of a Cold Chain Capacity of -60 degrees C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.
    J Infect Dis. 2018;217.
    >> Share

  414. GARLAND SM, Pitisuttithum P, Ngan HYS, Cho CH, et al
    Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.
    J Infect Dis. 2018 May 15. pii: 4996119. doi: 10.1093.
    >> Share

  415. FARMAKI PF, Chini MC, Mangafas NM, Tzanoudaki MT, et al
    Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.
    J Infect Dis. 2018 May 2. pii: 4990938. doi: 10.1093.
    >> Share

    April 2018
  416. CARROLL TD, Jegaskanda S, Matzinger SR, Fritts L, et al
    A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge.
    J Infect Dis. 2018 Apr 26. pii: 4986227. doi: 10.1093.
    >> Share

  417. JOYCE JC, Carroll TD, Collins ML, Chen MH, et al
    A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.
    J Infect Dis. 2018 Apr 26. pii: 4986788. doi: 10.1093.
    >> Share

  418. MAY S, Mandal S, Keel P, Haywood B, et al
    Hepatitis B virus immunisation and neonatal acquisition of persistent infection in England and Wales.
    J Infect Dis. 2018 Apr 24. pii: 4982944. doi: 10.1093.
    >> Share

  419. AMLABU E, Mensah-Brown H, Nyarko PB, Akuh OA, et al
    Functional Characterization of Plasmodium falciparum Surface Related Antigen (PfSRA) as a Potential Blood-Stage Vaccine Target.
    J Infect Dis. 2018 Apr 18. pii: 4975396. doi: 10.1093.
    >> Share

  420. DE VRIES RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, et al
    Induction of Cross-Clade Antibody and T-Cell Responses by an MVA-Based Influenza H5N1 Vaccine in a Randomized Phase I/IIa Clinical Trial.
    J Infect Dis. 2018 Apr 18. pii: 4975691. doi: 10.1093.
    >> Share

  421. LIN KY, Hsieh SM, Sheng WH, Lo YC, et al
    Comparable serologic responses to 2 different combinations of inactivated HAV vaccines in HIV-positive patients during the acute hepatitis A outbreak in Taiwan.
    J Infect Dis. 2018 Apr 16. pii: 4972613. doi: 10.1093.
    >> Share

  422. BADEN LR, Walsh SR, Seaman MS, Cohen YZ, et al
    First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
    J Infect Dis. 2018 Apr 13. pii: 4969772. doi: 10.1093.
    >> Share

  423. HAIDARA FC, Tapia MD, Sow SO, Doumbia M, et al
    Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants.
    J Infect Dis. 2018 Apr 12. pii: 4969416. doi: 10.1093.
    >> Share

  424. ZIMMERMANN P, Finn A, Curtis N
    Does BCG Vaccination Protect Against Non-Tuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis.
    J Infect Dis. 2018 Apr 7. pii: 4964710. doi: 10.1093.
    >> Share

    March 2018
  425. LANGLEY JM, MacDonald LD, Weir GM, MacKinnon-Cameron D, et al
    A Respiratory Syncytial Virus vaccine based on the Small Hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study.
    J Infect Dis. 2018 Mar 30. pii: 4956800. doi: 10.1093.
    >> Share

  426. MANNING JE, Morens DM, Kamhawi S, Valenzuela JG, et al
    Mosquito saliva: the hope for a universal arbovirus vaccine?
    J Infect Dis. 2018 Mar 29. pii: 4956143. doi: 10.1093.
    >> Share

  427. GUO Q, Chan JF, Poon VK, Wu S, et al
    Immunization with a Novel Human type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
    J Infect Dis. 2018 Mar 29. pii: 4956202. doi: 10.1093.
    >> Share

  428. FENG G, Boyle MJ, Cross N, Chan JA, et al
    Human immunization with a polymorphic malaria vaccine candidate induced antibodies to conserved epitopes that promote functional antibodies to multiple parasite strains.
    J Infect Dis. 2018 Mar 23. pii: 4952401. doi: 10.1093.
    >> Share

  429. PATEL EU, Grabowski MK, Eisenberg AL, Packman ZR, et al
    Increases in Human Papillomavirus Vaccination Among Adolescent and Young Adult Males in the United States, 2011-2016.
    J Infect Dis. 2018 Mar 23. pii: 4951824. doi: 10.1093.
    >> Share

  430. ANGRISANO F, Blagborough AM
    Understanding human-derived antibodies generated by polymorphic malaria vaccine against merozoite surface protein 2.
    J Infect Dis. 2018 Mar 23. pii: 4952403. doi: 10.1093.
    >> Share

  431. SCHLEISS MR
    Searching for a Serological Correlate of Protection for a CMV Vaccine.
    J Infect Dis. 2018 Mar 8. pii: 4924674. doi: 10.1093.
    >> Share

  432. BARANIAK I, Kropff B, McLean GR, Pichon S, et al
    Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia.
    J Infect Dis. 2018 Mar 8. pii: 4924673. doi: 10.1093.
    >> Share

  433. ROGAWSKI ET, Platts-Mills JA, Colgate ER, Haque R, et al
    Quantifying the Impact of Natural Immunity on Rotavirus Vaccine Efficacy Estimates: A Clinical Trial in Dhaka, Bangladesh (PROVIDE) and a Simulation Study.
    J Infect Dis. 2018;217:861-868.
    >> Share

  434. BUCHHOLZ UJ, Cunningham CK, Muresan P, Gnanashanmugam D, et al
    Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    J Infect Dis. 2018 Mar 2. pii: 4917539. doi: 10.1093.
    >> Share

  435. POLACK FP
    Crafting Live-Attenuated Vaccines Against Respiratory Syncytial Virus.
    J Infect Dis. 2018 Mar 2. pii: 4917537. doi: 10.1093.
    >> Share

  436. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.
    J Infect Dis. 2018 Mar 2. pii: 4917538. doi: 10.1093.
    >> Share

    February 2018
  437. ERBELDING EJ, Post D, Stemmy E, Roberts PC, et al
    A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
    J Infect Dis. 2018 Feb 28. pii: 4904047. doi: 10.1093.
    >> Share

  438. CUNNINGHAM AL, Heineman TC, Lal H, Godeaux O, et al
    Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged >/=50 Years.
    J Infect Dis. 2018 Feb 26. pii: 4911103. doi: 10.1093.
    >> Share

  439. YOUNG-XU Y, Van Aalst R, Mahmud SM, Rothman KJ, et al
    Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients.
    J Infect Dis. 2018 Feb 14. pii: 4858294. doi: 10.1093.
    >> Share

  440. KOJIC EM, Conley L, Bush T, Cu-Uvin S, et al
    Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study
    J Infect Dis. 2018 Feb 14. pii: 4857222. doi: 10.1093.
    >> Share

  441. BIERING-SORENSEN S, Jensen KJ, Monterio I, Ravn H, et al
    Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials.
    J Infect Dis. 2018;217:759-766.
    >> Share

  442. LO NC, Gupta R, Stanaway JD, Garrett DO, et al
    Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study.
    J Infect Dis. 2018 Feb 12. pii: 4851280. doi: 10.1093.
    >> Share

  443. ZENKLUSEN I, Jongo S, Abdulla S, Ramadhani K, et al
    Immunization of malaria pre-exposed volunteers with PfSPZ Vaccine elicits long-lived IgM invasion-inhibitory and complement-fixing antibodies.
    J Infect Dis. 2018 Feb 8. pii: 4845622. doi: 10.1093.
    >> Share

  444. MACHALEK DA, Garland SM, Brotherton JML, Bateson D, et al
    Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination.
    J Infect Dis. 2018 Feb 7. pii: 4841780. doi: 10.1093.
    >> Share

  445. FREYNE B, Donath S, Germano S, Gardiner K, et al
    Neonatal BCG vaccination influences cytokine responses to Toll-like receptor ligands and heterologous antigens.
    J Infect Dis. 2018 Feb 3. pii: 4837044. doi: 10.1093.
    >> Share

  446. DONKEN R, King AJ, Bogaards JA, Woestenberg PJ, et al
    High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females.
    J Infect Dis. 2018 Feb 2. pii: 4835373. doi: 10.1093.
    >> Share

  447. LEVIN MJ, Cai GY, Lee KS, Rouphael NG, et al
    Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.
    J Infect Dis. 2018 Feb 2. pii: 4835758. doi: 10.1093.
    >> Share

  448. POLLOCK KGJ
    Sustained cross-protection of the bivalent HPV vaccine.
    J Infect Dis. 2018 Feb 2. pii: 4835375. doi: 10.1093.
    >> Share

  449. BERAN J, Lickliter JD, Schwarz TF, Johnson C, et al
    Safety and immunogenicity of 3 formulations of an investigational respiratory syncytial virus vaccine in non-pregnant women: results from two phase II trials.
    J Infect Dis. 2018 Feb 1. pii: 4833521. doi: 10.1093.
    >> Share

  450. SHANG L, Smith AJ, Duan L, Perkey KE, et al
    Vaccine-associated maintenance of epithelial integrity correlated with protection against virus entry.
    J Infect Dis. 2018 Feb 1. pii: 4833184. doi: 10.1093.
    >> Share

    January 2018
  451. PIPKINS HR, Bradshaw JL, Keller LE, McDaniel LS, et al
    Virulence of an Encapsulated Streptococcus pneumoniae is Increased Upon Expression of Pneumococcal Surface Protein K.
    J Infect Dis. 2018 Jan 31. pii: 4830491. doi: 10.1093.
    >> Share

  452. LEE B, Dickson DM, deCamp AC, Colgate ER, et al
    Histoblood Group Antigen Phenotype Determines Susceptibility to Genotype-specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
    J Infect Dis. 2018 Jan 30. pii: 4829672. doi: 10.1093.
    >> Share

  453. MALHOTRA I, LaBeaud AD, Morris N, McKibben M, et al
    Cord Blood Anti-Parasite IL-10 as Risk Marker for Compromised Vaccine Immunogenicity in Early Childhood.
    J Infect Dis. 2018 Jan 30. pii: 4829506. doi: 10.1093.
    >> Share

  454. JUNG J, Ko SJ, Oh HS, Moon SM, et al
    Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome.
    J Infect Dis. 2018 Jan 24. pii: 4823438. doi: 10.1093.
    >> Share

  455. CHENG AC, Subbarao K
    Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle.
    J Infect Dis. 2018 Jan 18. pii: 4816917. doi: 10.1093.
    >> Share

  456. FLANNERY B, Smith C, Garten RJ, Levine MZ, et al
    Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
    J Infect Dis. 2018 Jan 18. pii: 4816916. doi: 10.1093.
    >> Share

  457. WILSON P, Parr JB, Jhaveri R, Meshnick SR, et al
    Call to action: Prevention of mother-to-child transmission of hepatitis B in Africa.
    J Infect Dis. 2018 Jan 17. pii: 4812591. doi: 10.1093.
    >> Share

  458. CHIU SS, Kwan MYW, Feng S, Wong JSC, et al
    Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/17.
    J Infect Dis. 2018 Jan 16. pii: 4810661. doi: 10.1093.
    >> Share

  459. KAPIL P, Papin JF, Wolf RF, Zimmerman LI, et al
    Maternal Vaccination with a Mono-component Pertussis Toxoid Vaccine is Sufficient to Protect Infants in a Baboon Model of Whooping Cough.
    J Infect Dis. 2018 Jan 15. pii: 4808590. doi: 10.1093.
    >> Share

  460. CAPEDING MR, Alberto ER, Bouckenooghe A, Laot TM, et al
    Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
    J Infect Dis. 2018 Jan 9. pii: 4794746. doi: 10.1093.
    >> Share

  461. PRINGLE KD, Burke RM, Steiner CA, Parashar UD, et al
    Trends in Rate of Seizure-Associated Hospitalizations Among Children <5 Years Old Before and After Rotavirus Vaccine Introduction in the United Sates, 2000-2013.
    J Infect Dis. 2018 Jan 9. pii: 4796788. doi: 10.1093.
    >> Share

  462. FONG Y, Shen X, Ashley VC, Deal A, et al
    Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505.
    J Infect Dis. 2018 Jan 8. pii: 4792964. doi: 10.1093.
    >> Share

  463. BRICKLEY EB, Strauch CB, Wieland-Alter WF, Connor RI, et al
    Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    J Infect Dis. 2018 Jan 3. pii: 4788281. doi: 10.1093.
    >> Share

  464. SUTTER RW
    Unraveling the Mucosal Immunity of Inactivated Poliovirus Vaccine.
    J Infect Dis. 2018 Jan 3. pii: 4788256. doi: 10.1093.
    >> Share

  465. GIRI S, Kumar N, Dhanapal P, Venkatesan J, et al
    The quantity of vaccine poliovirus shedding determines the titer of the serum neutralizing antibody response in Indian children vaccinated with oral vaccine.
    J Infect Dis. 2018 Jan 2. pii: 4782493. doi: 10.1093.
    >> Share

    December 2017
  466. RAMILO O, Rodriguez-Fernandez R, Mejias A
    One Step Forward in the Road Toward a Universal Influenza Vaccine.
    J Infect Dis. 2017;217:1-2.
    >> Share

  467. MAJUMDAR M, Klapsa D, Wilton T, Akello J, et al
    Isolation of vaccine-like poliovirus strains in sewage samples from the UK.
    J Infect Dis. 2017 Dec 22. pii: 4772162. doi: 10.1093.
    >> Share

  468. MEYER M, Huang E, Yuzhakov O, Ramanathan P, et al
    Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease.
    J Infect Dis. 2017 Dec 21. pii: 4770157. doi: 10.1093.
    >> Share

  469. DURBIN AP, Whitehead SS
    Zika Vaccines: Role for Controlled Human Infection.
    J Infect Dis. 2017;216.
    >> Share

  470. MORABITO KM, Graham BS
    Zika Virus Vaccine Development.
    J Infect Dis. 2017;216.
    >> Share

  471. GRUBER MF, Farizo KM, Pratt RD, Fink DL, et al
    Clinical Development Strategies and Considerations for Zika Vaccine Licensure.
    J Infect Dis. 2017;216.
    >> Share

  472. OSUNA CE, Whitney JB
    Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic Development.
    J Infect Dis. 2017;216.
    >> Share

  473. PRIYAMVADA L, Suthar MS, Ahmed R, Wrammert J, et al
    Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity.
    J Infect Dis. 2017;216.
    >> Share

  474. MORENS DM, Fauci AS
    Pandemic Zika: A Formidable Challenge to Medicine and Public Health.
    J Infect Dis. 2017;216.
    >> Share

  475. VOIGT EA, Haralambieva IH, Larrabee BL, Kennedy RB, et al
    Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.
    J Infect Dis. 2017 Dec 14. pii: 4743250. doi: 10.1093.
    >> Share

  476. MADARAS-KELLY K, Remington R, Hruza H, Xu D, et al
    The Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Post-Influenza Deaths.
    J Infect Dis. 2017 Dec 9. pii: 4718125. doi: 10.1093.
    >> Share

  477. YOUNG B, Sadarangani S, Jiang L, Wilder-Smith A, et al
    The Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis and Meta-regression of Test-Negative Design Case-control Studies.
    J Infect Dis. 2017 Dec 6. pii: 4694421. doi: 10.1093.
    >> Share

  478. OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
    Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study.
    J Infect Dis. 2017 Dec 5. pii: 4693945. doi: 10.1093.
    >> Share

  479. BURN C, Ramsey N, Garforth SJ, Almo S, et al
    An HSV-2 single-cycle candidate vaccine deleted in glycoprotein D, DeltagD-2, protects male mice from lethal skin challenge with clinical isolates of HSV-1 and HSV-2.
    J Infect Dis. 2017 Dec 5. pii: 4693944. doi: 10.1093.
    >> Share

  480. LIU WC, Lin CS, Yeh CC, Wu HY, et al
    Effect of Influenza Vaccination Against Postoperative Pneumonia and Mortality for Geriatric Patients Receiving Major Surgery: A Nationwide Matched Study.
    J Infect Dis. 2017 Dec 5. pii: 4690590. doi: 10.1093.
    >> Share

  481. HAGAN JE, Takashima Y, Sarankhuu A, Dashpagma O, et al
    Risk Factors for Measles Virus Infection Among Adults During a Large Outbreak in Postelimination Era in Mongolia, 2015.
    J Infect Dis. 2017;216:1187-1195.
    >> Share

    November 2017
  482. MOODIE Z, Juraska M, Huang Y, Zhuang Y, et al
    Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America.
    J Infect Dis. 2017 Nov 29. pii: 4675250. doi: 10.1093.
    >> Share

  483. SCHERER EM, Smith RA, Carter JJ, Wipf GC, et al
    Analysis of memory B cell responses reveals suboptimal dosing schedule of a licensed vaccine.
    J Infect Dis. 2017 Nov 24. pii: 4657105. doi: 10.1093.
    >> Share

  484. HIRAMATSU H, Suzuki R, Nagatani A, Boda H, et al
    Rotavirus vaccination can be performed without viral dissemination in the Neonatal Intensive Care Unit.
    J Infect Dis. 2017 Nov 20. doi: 10.1093.
    >> Share

  485. DREW DR, Sanders PR, Weiss G, Gilson PR, et al
    Functional conservation of the AMA1 host-cell invasion ligand between P. falciparum and P. vivax: a novel platform to accelerate vaccine and drug development.
    J Infect Dis. 2017 Nov 20. doi: 10.1093.
    >> Share

  486. CHEN HL, Wen WH, Chang MH
    Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission.
    J Infect Dis. 2017;216.
    >> Share

  487. OLDFIELD NJ, Green LR, Parkhill J, Bayliss CD, et al
    Limited impact of adolescent meningococcal ACWY vaccination on group W carriage in university students.
    J Infect Dis. 2017 Nov 15. doi: 10.1093.
    >> Share

  488. LEROUX-ROELS G, Cramer JP, Mendelman PM, Sherwood J, et al
    Safety and immunogenicity of different formulations of norovirus vaccine candidate in healthy adults: a randomized, controlled, double-blind clinical trial.
    J Infect Dis. 2017 Nov 13. doi: 10.1093.
    >> Share

  489. WOESTENBERG PJ, King AJ, van Benthem BHB, Donken R, et al
    Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors.
    J Infect Dis. 2017 Nov 11. doi: 10.1093.
    >> Share

  490. NOVAKOVIC D, Cheng ATL, Zurynski Y, Booy R, et al
    A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.
    J Infect Dis. 2017 Nov 9. doi: 10.1093.
    >> Share

  491. DONOVAN B, Callander D
    Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue.
    J Infect Dis. 2017 Nov 9. doi: 10.1093.
    >> Share

  492. SALEEM AF, Mach O, Yousafzai MT, Khan A, et al
    Immunogenicity of Different Routine Poliovirus Vaccination Schedules: a Randomized Controlled Trial, Karachi, Pakistan.
    J Infect Dis. 2017 Nov 6. doi: 10.1093.
    >> Share

  493. VANDERVEN HA, Jegaskanda S, Wines BD, Hogarth PM, et al
    Antibody-dependent cellular cytotoxicity (ADCC) responses to seasonal influenza vaccination in older adults.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    >> Share

  494. LIN SM, Jang AY, Zhi Y, Gao S, et al
    Immunization with a Latch Peptide Provides Serotype-Independent Protection against Group B Streptococcus Infection in Mice.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    >> Share

    October 2017
  495. SICRE DE FONTBRUNE F, Arnaud C, Cheminant M, Boulay A, et al
    Immunogenicity and safety of yellow fever vaccine in allogeneic hematopoietic stem cell transplant recipients after withdrawal of immunosuppressive therapy.
    J Infect Dis. 2017 Oct 26. doi: 10.1093.
    >> Share

  496. SKOWRONSKI DM, Chambers C, De Serres G
    Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    >> Share

  497. SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al
    Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada.
    J Infect Dis. 2017 Oct 4. doi: 10.1093.
    >> Share

    September 2017
  498. BELONGIA E
    Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Sep 27. doi: 10.1093.
    >> Share

  499. OXMAN MN, Harbecke R, Koelle DM
    Clinical Usage of the Candidate Adjuvanted HZ/su Zoster Vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  500. SCHWARZ TF, Aggarwal N, Moeckesch B, Schenkenberger I, et al
    Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  501. GRUPPING K, Campora L, Douha M, Heineman TC, et al
    Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  502. FALLOON J, Yu J, Esser MT, Villafana T, et al
    An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    >> Share

  503. NICHOLSON E, Piedra PA
    Local Versus Global Enterovirus (EV) Surveillance: A Discussion For The Need for Active Surveillance To Guide EV A71 Vaccines.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    >> Share

  504. LANGLEY JM
    Vaccine Prevention of Respiratory Syncytial Virus in Older Adults: The Work Continues.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    >> Share

  505. LEVINE MZ, Holiday C, Liu F, Jefferson S, et al
    Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.
    J Infect Dis. 2017;216.
    >> Share

  506. JONES EN, Amoah S, Cao W, Sambhara S, et al
    An Adjuvanted A(H5N1) Subvirion Vaccine Elicits Virus-Specific Antibody Response and Improves Protection Against Lethal Influenza Viral Challenge in Mouse Model of Protein Energy Malnutrition.
    J Infect Dis. 2017;216.
    >> Share

  507. PODDIGHE D
    2-Dose Schedule of AS04-Adjuvanted Human Papillomavirus Types 16/18 Vaccine.
    J Infect Dis. 2017;216:782-783.
    >> Share

  508. TAI CS, Wu JF, Chen HL, Ni YH, et al
    The Impact of Hepatitis B Vaccine Failure on Long-term Natural Course of Chronic Hepatitis B Virus Infection in Hepatitis B e Antigen-Seropositive Children.
    J Infect Dis. 2017;216:662-669.
    >> Share

  509. TORRESI J, Richmond PC, Heron LG, Qiao M, et al
    Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    >> Share

  510. DROLET M, Laprise JF, Brotherton JML, Donovan B, et al
    The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation.
    J Infect Dis. 2017 Sep 12. doi: 10.1093.
    >> Share

  511. DUNKLE LM, Izikson R, Patriarca PA, Goldenthal KL, et al
    Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    >> Share

  512. AKE JA, Schuetz A, Pegu P, Wieczorek L, et al
    Safety and Immunogenicity of PENNVAX(R)-G DNA Prime Administered by Biojector(R) 2000 or CELLECTRA(R) Electroporation Device with Modified Vaccinia Ankara-CMDR Boost.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    >> Share

  513. NING T, Wolfe A, Nie J, Huang W, et al
    Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    >> Share

  514. OLIVER SE, Unger ER, Lewis R, McDaniel D, et al
    Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
    J Infect Dis. 2017;216:594-603.
    >> Share

    August 2017
  515. MCNAMARA LA, Thomas JD, MacNeil J, Chang HY, et al
    Meningococcal Carriage Following a University Serogroup B Meningococcal Disease Outbreak and Vaccination Campaign with MenB-4C and MenB-FHbp - Oregon, 2015-2016.
    J Infect Dis. 2017 Aug 26. doi: 10.1093.
    >> Share

  516. LEHTINEN T, Soderlund-Strand A, Petaja T, Eriksson T, et al
    Human papillomavirus (HPV) prevalence in adolescent males four years post HPV16/18 vaccination.
    J Infect Dis. 2017 Aug 24. doi: 10.1093.
    >> Share

  517. MODROF J, Tille B, Farcet MR, McVey J, et al
    Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins:is an Increase by Re-Vaccination of Plasma Donors possible?
    J Infect Dis. 2017 Aug 18. doi: 10.1093.
    >> Share

  518. NEUZIL KM, Chen WH
    Influenza Vaccines for Older Persons: Progress and Pitfalls.
    J Infect Dis. 2017;216:397-398.
    >> Share

  519. ANDREW MK, Shinde V, Ye L, Hatchette T, et al
    The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
    J Infect Dis. 2017;216:405-414.
    >> Share

  520. VAN BEEK J, Veenhoven RH, Bruin JP, van Boxtel RAJ, et al
    Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.
    J Infect Dis. 2017;216:415-424.
    >> Share

  521. MCELHANEY JE, McNeil SA
    Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults.
    J Infect Dis. 2017;216:399-401.
    >> Share

  522. LIBRATY DH
    Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
    J Infect Dis. 2017;216:502-503.
    >> Share

    July 2017
  523. PATEL M, Cochi S
    Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
    J Infect Dis. 2017;216.
    >> Share

  524. ZIPURSKY S, Vandelaer J, Brooks A, Dietz V, et al
    Polio Endgame: Lessons Learned From the Immunization Systems Management Group.
    J Infect Dis. 2017;216.
    >> Share

  525. PEDREIRA C, Thrush E, Jauregui B
    Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas.
    J Infect Dis. 2017;216.
    >> Share

    March 2017
  526. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017;215:841-843.
    >> Share

  527. COHEN JI
    Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.
    J Infect Dis. 2017;215:844-846.
    >> Share

  528. MONTO AS
    Moving Toward Improved Influenza Vaccines.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    >> Share

    December 2016
  529. HADLER JL
    Christmas-New Year influenza lull: not too late for vaccination.
    J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
    >> Share

  530. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016.
    >> Share

    May 2016
  531. VIROJANAPIROM P, Lumlertdacha B, Wipattanakitchareon A, Hemachudha T, et al
    T-705 as a potential therapeutic in rabies.
    J Infect Dis. 2016.
    >> Share

    February 2016
  532. MASCITELLI L, Goldstein MR
    How regulatory T cells induction by statin drugs may impair influenza vaccine immunogenicity and effectiveness.
    J Infect Dis. 2016.
    >> Share

  533. TITA AT, Andrews WW
    Influenza Vaccination and Antiviral Therapy in Pregnant Women.
    J Infect Dis. 2016.
    >> Share

    January 2016
  534. VAN DAMME P
    Long-term Protection After Hepatitis B Vaccine.
    J Infect Dis. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016